#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


Text=Neural Predictors of Initiating Alcohol Use during Adolescence Background Underage drinking is widely recognized as a leading public health and social problem for adolescents in the United States.
1-1	0-6	Neural	_
1-2	7-17	Predictors	_
1-3	18-20	of	_
1-4	21-31	Initiating	_
1-5	32-39	Alcohol	_
1-6	40-43	Use	http://maven.renci.org/NeuroBridge/neurobridge#CurrentUse
1-7	44-50	during	_
1-8	51-62	Adolescence	_
1-9	63-73	Background	_
1-10	74-82	Underage	_
1-11	83-91	drinking	_
1-12	92-94	is	_
1-13	95-101	widely	_
1-14	102-112	recognized	_
1-15	113-115	as	_
1-16	116-117	a	_
1-17	118-125	leading	_
1-18	126-132	public	_
1-19	133-139	health	_
1-20	140-143	and	_
1-21	144-150	social	_
1-22	151-158	problem	_
1-23	159-162	for	_
1-24	163-174	adolescents	_
1-25	175-177	in	_
1-26	178-181	the	_
1-27	182-188	United	_
1-28	189-195	States	_
1-29	196-197	.	_

Text=Being able to identify at-risk children before they initiate heavy alcohol use could have immense clinical and public health implications; however, few investigations have explored individual-level precursors of adolescent substance use.
2-1	198-203	Being	_
2-2	204-208	able	_
2-3	209-211	to	_
2-4	212-220	identify	_
2-5	221-228	at-risk	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
2-6	229-237	children	_
2-7	238-244	before	_
2-8	245-249	they	_
2-9	250-258	initiate	_
2-10	259-264	heavy	_
2-11	265-272	alcohol	_
2-12	273-276	use	_
2-13	277-282	could	_
2-14	283-287	have	_
2-15	288-295	immense	_
2-16	296-304	clinical	_
2-17	305-308	and	_
2-18	309-315	public	_
2-19	316-322	health	_
2-20	323-335	implications	_
2-21	336-337	;	_
2-22	338-345	however	_
2-23	346-347	,	_
2-24	348-351	few	_
2-25	352-366	investigations	_
2-26	367-371	have	_
2-27	372-380	explored	_
2-28	381-397	individual-level	_
2-29	398-408	precursors	_
2-30	409-411	of	_
2-31	412-422	adolescent	_
2-32	423-432	substance	_
2-33	433-436	use	_
2-34	437-438	.	_

Text=This prospective investigation used machine learning with demographic, neurocognitive, and neuroimaging data in substance-naïve adolescents to predict alcohol use initiation by age 18.
3-1	439-443	This	_
3-2	444-455	prospective	_
3-3	456-469	investigation	_
3-4	470-474	used	_
3-5	475-482	machine	_
3-6	483-491	learning	_
3-7	492-496	with	_
3-8	497-508	demographic	_
3-9	509-510	,	_
3-10	511-525	neurocognitive	_
3-11	526-527	,	_
3-12	528-531	and	_
3-13	532-544	neuroimaging	_
3-14	545-549	data	_
3-15	550-552	in	_
3-16	553-568	substance-naïve	http://maven.renci.org/NeuroBridge/neurobridge#PsychoactiveSubstanceAbuse
3-17	569-580	adolescents	http://maven.renci.org/NeuroBridge/neurobridge#PsychoactiveSubstanceAbuse
3-18	581-583	to	_
3-19	584-591	predict	_
3-20	592-599	alcohol	_
3-21	600-603	use	_
3-22	604-614	initiation	_
3-23	615-617	by	_
3-24	618-621	age	_
3-25	622-624	18	_
3-26	625-626	.	_

Text=Materials and Methods Participants (N=137) were healthy substance-naïve adolescents (ages 12–14) who underwent neuropsychological testing and structural and functional magnetic resonance imaging (sMRI and fMRI), then were followed annually.
4-1	627-636	Materials	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
4-2	637-640	and	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
4-3	641-648	Methods	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
4-4	649-661	Participants	_
4-5	662-663	(	_
4-6	664-669	N=137	_
4-7	670-671	)	_
4-8	672-676	were	_
4-9	677-684	healthy	_
4-10	685-700	substance-naïve	http://maven.renci.org/NeuroBridge/neurobridge#PsychoactiveSubstanceAbuse
4-11	701-712	adolescents	http://maven.renci.org/NeuroBridge/neurobridge#PsychoactiveSubstanceAbuse
4-12	713-714	(	_
4-13	715-719	ages	_
4-14	720-725	12–14	_
4-15	726-727	)	_
4-16	728-731	who	_
4-17	732-741	underwent	_
4-18	742-760	neuropsychological	http://maven.renci.org/NeuroBridge/neurobridge#CambridgeNeuropsychologicalTestAutomatedBattery
4-19	761-768	testing	http://maven.renci.org/NeuroBridge/neurobridge#CambridgeNeuropsychologicalTestAutomatedBattery
4-20	769-772	and	_
4-21	773-783	structural	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
4-22	784-787	and	http://maven.renci.org/NeuroBridge/neurobridge#StructuralImaging
4-23	788-798	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-24	799-807	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-25	808-817	resonance	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-26	818-825	imaging	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-27	826-827	(	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-28	828-832	sMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-29	833-836	and	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-30	837-841	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-31	842-843	)	_
4-32	844-845	,	_
4-33	846-850	then	_
4-34	851-855	were	_
4-35	856-864	followed	_
4-36	865-873	annually	_
4-37	874-875	.	_

Text=By age 18, 70 youth (51%) initiated moderate-to-heavy alcohol use and 67 remained non-users.
5-1	876-878	By	_
5-2	879-882	age	_
5-3	883-885	18	_
5-4	886-887	,	_
5-5	888-890	70	_
5-6	891-896	youth	_
5-7	897-898	(	_
5-8	899-901	51	_
5-9	902-903	%	_
5-10	904-905	)	_
5-11	906-915	initiated	_
5-12	916-933	moderate-to-heavy	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
5-13	934-941	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
5-14	942-945	use	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
5-15	946-949	and	_
5-16	950-952	67	_
5-17	953-961	remained	_
5-18	962-971	non-users	_
5-19	972-973	.	_

Text=Random forests classification generated individual alcohol use outcome predictions based on demographic, neuropsychological, sMRI, and fMRI data.
6-1	974-980	Random	_
6-2	981-988	forests	_
6-3	989-1003	classification	_
6-4	1004-1013	generated	_
6-5	1014-1024	individual	_
6-6	1025-1032	alcohol	_
6-7	1033-1036	use	_
6-8	1037-1044	outcome	_
6-9	1045-1056	predictions	_
6-10	1057-1062	based	_
6-11	1063-1065	on	_
6-12	1066-1077	demographic	_
6-13	1078-1079	,	_
6-14	1080-1098	neuropsychological	_
6-15	1099-1100	,	_
6-16	1101-1105	sMRI	http://maven.renci.org/NeuroBridge/neurobridge#Thing
6-17	1106-1107	,	_
6-18	1108-1111	and	_
6-19	1112-1116	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
6-20	1117-1121	data	_
6-21	1122-1123	.	_

Text=Results The final random forests model was 74% accurate, with good sensitivity (74%) and specificity (73%) and included 34 predictors contributing to alcohol use by age 18, including several demographic and behavioral factors (being male, higher socioeconomic status, early dating, more externalizing behaviors, positive alcohol expectancies), worse executive functioning, and thinner cortices and less brain activation in diffusely distributed regions of the brain.
7-1	1124-1131	Results	_
7-2	1132-1135	The	_
7-3	1136-1141	final	_
7-4	1142-1148	random	_
7-5	1149-1156	forests	_
7-6	1157-1162	model	_
7-7	1163-1166	was	_
7-8	1167-1169	74	_
7-9	1170-1171	%	_
7-10	1172-1180	accurate	_
7-11	1181-1182	,	_
7-12	1183-1187	with	_
7-13	1188-1192	good	_
7-14	1193-1204	sensitivity	_
7-15	1205-1206	(	_
7-16	1207-1209	74	_
7-17	1210-1211	%	_
7-18	1212-1213	)	_
7-19	1214-1217	and	_
7-20	1218-1229	specificity	_
7-21	1230-1231	(	_
7-22	1232-1234	73	_
7-23	1235-1236	%	_
7-24	1237-1238	)	_
7-25	1239-1242	and	_
7-26	1243-1251	included	_
7-27	1252-1254	34	_
7-28	1255-1265	predictors	_
7-29	1266-1278	contributing	_
7-30	1279-1281	to	_
7-31	1282-1289	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
7-32	1290-1293	use	_
7-33	1294-1296	by	_
7-34	1297-1300	age	_
7-35	1301-1303	18	_
7-36	1304-1305	,	_
7-37	1306-1315	including	_
7-38	1316-1323	several	_
7-39	1324-1335	demographic	_
7-40	1336-1339	and	_
7-41	1340-1350	behavioral	_
7-42	1351-1358	factors	_
7-43	1359-1360	(	_
7-44	1361-1366	being	_
7-45	1367-1371	male	_
7-46	1372-1373	,	_
7-47	1374-1380	higher	_
7-48	1381-1394	socioeconomic	_
7-49	1395-1401	status	_
7-50	1402-1403	,	_
7-51	1404-1409	early	_
7-52	1410-1416	dating	_
7-53	1417-1418	,	_
7-54	1419-1423	more	_
7-55	1424-1437	externalizing	_
7-56	1438-1447	behaviors	_
7-57	1448-1449	,	_
7-58	1450-1458	positive	_
7-59	1459-1466	alcohol	_
7-60	1467-1479	expectancies	_
7-61	1480-1481	)	_
7-62	1482-1483	,	_
7-63	1484-1489	worse	_
7-64	1490-1499	executive	_
7-65	1500-1511	functioning	_
7-66	1512-1513	,	_
7-67	1514-1517	and	_
7-68	1518-1525	thinner	_
7-69	1526-1534	cortices	_
7-70	1535-1538	and	_
7-71	1539-1543	less	_
7-72	1544-1549	brain	_
7-73	1550-1560	activation	_
7-74	1561-1563	in	_
7-75	1564-1573	diffusely	_
7-76	1574-1585	distributed	_
7-77	1586-1593	regions	_
7-78	1594-1596	of	_
7-79	1597-1600	the	_
7-80	1601-1606	brain	_
7-81	1607-1608	.	_

Text=Inclusion of neuropsychological, sMRI, and fMRI data significantly increased the prediction accuracy of the model.
8-1	1609-1618	Inclusion	_
8-2	1619-1621	of	_
8-3	1622-1640	neuropsychological	http://maven.renci.org/NeuroBridge/neurobridge#CambridgeNeuropsychologicalTestAutomatedBattery
8-4	1641-1642	,	_
8-5	1643-1647	sMRI	http://maven.renci.org/NeuroBridge/neurobridge#Thing
8-6	1648-1649	,	_
8-7	1650-1653	and	_
8-8	1654-1658	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
8-9	1659-1663	data	_
8-10	1664-1677	significantly	_
8-11	1678-1687	increased	_
8-12	1688-1691	the	_
8-13	1692-1702	prediction	_
8-14	1703-1711	accuracy	_
8-15	1712-1714	of	_
8-16	1715-1718	the	_
8-17	1719-1724	model	_
8-18	1725-1726	.	_

Text=Discussion Identification of at-risk youth is not validated for clinical use.
9-1	1727-1737	Discussion	_
9-2	1738-1752	Identification	_
9-3	1753-1755	of	_
9-4	1756-1763	at-risk	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
9-5	1764-1769	youth	_
9-6	1770-1772	is	_
9-7	1773-1776	not	_
9-8	1777-1786	validated	_
9-9	1787-1790	for	_
9-10	1791-1799	clinical	_
9-11	1800-1803	use	_
9-12	1804-1805	.	_

Text=Its value is for research to address brain mechanisms that predispose to early drinking.
10-1	1806-1809	Its	_
10-2	1810-1815	value	_
10-3	1816-1818	is	_
10-4	1819-1822	for	_
10-5	1823-1831	research	_
10-6	1832-1834	to	_
10-7	1835-1842	address	_
10-8	1843-1848	brain	_
10-9	1849-1859	mechanisms	_
10-10	1860-1864	that	_
10-11	1865-1875	predispose	_
10-12	1876-1878	to	_
10-13	1879-1884	early	_
10-14	1885-1893	drinking	_
10-15	1894-1895	.	_

Text=MATERIALS AND METHODS Participants Participants were 137 healthy 12–14 year-olds (44% female) from a larger ongoing neuroimaging study recruited through flyers sent to households of students attending local middle schools (see Table 1).
11-1	1896-1905	MATERIALS	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
11-2	1906-1909	AND	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
11-3	1910-1917	METHODS	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
11-4	1918-1930	Participants	_
11-5	1931-1943	Participants	_
11-6	1944-1948	were	_
11-7	1949-1952	137	_
11-8	1953-1960	healthy	_
11-9	1961-1966	12–14	_
11-10	1967-1976	year-olds	_
11-11	1977-1978	(	_
11-12	1979-1981	44	_
11-13	1982-1983	%	_
11-14	1984-1990	female	_
11-15	1991-1992	)	_
11-16	1993-1997	from	_
11-17	1998-1999	a	_
11-18	2000-2006	larger	_
11-19	2007-2014	ongoing	_
11-20	2015-2027	neuroimaging	_
11-21	2028-2033	study	_
11-22	2034-2043	recruited	_
11-23	2044-2051	through	_
11-24	2052-2058	flyers	_
11-25	2059-2063	sent	_
11-26	2064-2066	to	_
11-27	2067-2077	households	_
11-28	2078-2080	of	_
11-29	2081-2089	students	_
11-30	2090-2099	attending	_
11-31	2100-2105	local	_
11-32	2106-2112	middle	_
11-33	2113-2120	schools	_
11-34	2121-2122	(	_
11-35	2123-2126	see	_
11-36	2127-2132	Table	_
11-37	2133-2134	1	_
11-38	2135-2136	)	_
11-39	2137-2138	.	_

Text=Extensive screening and background information were obtained from the youth, their biological parent, and one other parent or close relative.
12-1	2139-2148	Extensive	_
12-2	2149-2158	screening	_
12-3	2159-2162	and	_
12-4	2163-2173	background	_
12-5	2174-2185	information	_
12-6	2186-2190	were	_
12-7	2191-2199	obtained	_
12-8	2200-2204	from	_
12-9	2205-2208	the	_
12-10	2209-2214	youth	_
12-11	2215-2216	,	_
12-12	2217-2222	their	_
12-13	2223-2233	biological	_
12-14	2234-2240	parent	_
12-15	2241-2242	,	_
12-16	2243-2246	and	_
12-17	2247-2250	one	_
12-18	2251-2256	other	_
12-19	2257-2263	parent	_
12-20	2264-2266	or	_
12-21	2267-2272	close	_
12-22	2273-2281	relative	_
12-23	2282-2283	.	_

Text=All primary informants lived with the youth.
13-1	2284-2287	All	_
13-2	2288-2295	primary	_
13-3	2296-2306	informants	_
13-4	2307-2312	lived	_
13-5	2313-2317	with	_
13-6	2318-2321	the	_
13-7	2322-2327	youth	_
13-8	2328-2329	.	_

Text=The study protocol was executed in accordance with the standards approved by the University of California, San Diego Human Research Protections Program.
14-1	2330-2333	The	_
14-2	2334-2339	study	_
14-3	2340-2348	protocol	_
14-4	2349-2352	was	_
14-5	2353-2361	executed	_
14-6	2362-2364	in	_
14-7	2365-2375	accordance	_
14-8	2376-2380	with	_
14-9	2381-2384	the	_
14-10	2385-2394	standards	_
14-11	2395-2403	approved	_
14-12	2404-2406	by	_
14-13	2407-2410	the	_
14-14	2411-2421	University	_
14-15	2422-2424	of	_
14-16	2425-2435	California	_
14-17	2436-2437	,	_
14-18	2438-2441	San	_
14-19	2442-2447	Diego	_
14-20	2448-2453	Human	_
14-21	2454-2462	Research	_
14-22	2463-2474	Protections	_
14-23	2475-2482	Program	_
14-24	2483-2484	.	_

Text=Strict exclusionary criteria for project entry included: experience with alcohol or drugs, defined as ≥10 total days in their life on which drinking had occurred, or> 2 drinks in a week (i.e., two drinks on one occasion or one drink on two occasions in the same week); ≥3 lifetime experiences with marijuana and any use in the past three months; ≥5 lifetime cigarette uses; and any history of other intoxicant use; any suggestion of prenatal alcohol (> 2 drinks during a given week) or any illicit drug exposure; premature birth (i.e., born prior to 35th gestational week); history of any neurological or DSM-IV Axis I disorder, determined by the NIMH Diagnostic Interview Schedule for Children –version 4.0, head trauma or loss of consciousness (> 2 minutes), chronic medical illness, learning disability or mental retardation, or use of medications potentially affecting the brain; contraindication to MRI (e.g., braces); inadequate comprehension of English; and non-correctable sensory problems.
15-1	2485-2491	Strict	_
15-2	2492-2504	exclusionary	_
15-3	2505-2513	criteria	_
15-4	2514-2517	for	_
15-5	2518-2525	project	_
15-6	2526-2531	entry	_
15-7	2532-2540	included	_
15-8	2541-2542	:	_
15-9	2543-2553	experience	_
15-10	2554-2558	with	_
15-11	2559-2566	alcohol	_
15-12	2567-2569	or	_
15-13	2570-2575	drugs	_
15-14	2576-2577	,	_
15-15	2578-2585	defined	_
15-16	2586-2588	as	_
15-17	2589-2592	≥10	_
15-18	2593-2598	total	_
15-19	2599-2603	days	_
15-20	2604-2606	in	_
15-21	2607-2612	their	_
15-22	2613-2617	life	_
15-23	2618-2620	on	_
15-24	2621-2626	which	_
15-25	2627-2635	drinking	_
15-26	2636-2639	had	_
15-27	2640-2648	occurred	_
15-28	2649-2650	,	_
15-29	2651-2653	or	_
15-30	2654-2655	>	_
15-31	2656-2657	2	_
15-32	2658-2664	drinks	_
15-33	2665-2667	in	_
15-34	2668-2669	a	_
15-35	2670-2674	week	_
15-36	2675-2676	(	_
15-37	2677-2681	i.e.	_
15-38	2682-2683	,	_
15-39	2684-2687	two	_
15-40	2688-2694	drinks	_
15-41	2695-2697	on	_
15-42	2698-2701	one	_
15-43	2702-2710	occasion	_
15-44	2711-2713	or	_
15-45	2714-2717	one	_
15-46	2718-2723	drink	_
15-47	2724-2726	on	_
15-48	2727-2730	two	_
15-49	2731-2740	occasions	_
15-50	2741-2743	in	_
15-51	2744-2747	the	_
15-52	2748-2752	same	_
15-53	2753-2757	week	_
15-54	2758-2759	)	_
15-55	2760-2761	;	_
15-56	2762-2764	≥3	_
15-57	2765-2773	lifetime	_
15-58	2774-2785	experiences	_
15-59	2786-2790	with	_
15-60	2791-2800	marijuana	_
15-61	2801-2804	and	_
15-62	2805-2808	any	_
15-63	2809-2812	use	_
15-64	2813-2815	in	_
15-65	2816-2819	the	_
15-66	2820-2824	past	_
15-67	2825-2830	three	_
15-68	2831-2837	months	_
15-69	2838-2839	;	_
15-70	2840-2842	≥5	_
15-71	2843-2851	lifetime	_
15-72	2852-2861	cigarette	_
15-73	2862-2866	uses	_
15-74	2867-2868	;	_
15-75	2869-2872	and	_
15-76	2873-2876	any	_
15-77	2877-2884	history	_
15-78	2885-2887	of	_
15-79	2888-2893	other	_
15-80	2894-2904	intoxicant	_
15-81	2905-2908	use	_
15-82	2909-2910	;	_
15-83	2911-2914	any	_
15-84	2915-2925	suggestion	_
15-85	2926-2928	of	_
15-86	2929-2937	prenatal	_
15-87	2938-2945	alcohol	_
15-88	2946-2947	(	_
15-89	2948-2949	>	_
15-90	2950-2951	2	_
15-91	2952-2958	drinks	_
15-92	2959-2965	during	_
15-93	2966-2967	a	_
15-94	2968-2973	given	_
15-95	2974-2978	week	_
15-96	2979-2980	)	_
15-97	2981-2983	or	_
15-98	2984-2987	any	_
15-99	2988-2995	illicit	_
15-100	2996-3000	drug	_
15-101	3001-3009	exposure	_
15-102	3010-3011	;	_
15-103	3012-3021	premature	_
15-104	3022-3027	birth	_
15-105	3028-3029	(	_
15-106	3030-3034	i.e.	_
15-107	3035-3036	,	_
15-108	3037-3041	born	_
15-109	3042-3047	prior	_
15-110	3048-3050	to	_
15-111	3051-3055	35th	_
15-112	3056-3067	gestational	_
15-113	3068-3072	week	_
15-114	3073-3074	)	_
15-115	3075-3076	;	_
15-116	3077-3084	history	_
15-117	3085-3087	of	_
15-118	3088-3091	any	_
15-119	3092-3104	neurological	_
15-120	3105-3107	or	_
15-121	3108-3114	DSM-IV	_
15-122	3115-3119	Axis	_
15-123	3120-3121	I	_
15-124	3122-3130	disorder	_
15-125	3131-3132	,	_
15-126	3133-3143	determined	_
15-127	3144-3146	by	_
15-128	3147-3150	the	_
15-129	3151-3155	NIMH	_
15-130	3156-3166	Diagnostic	_
15-131	3167-3176	Interview	_
15-132	3177-3185	Schedule	_
15-133	3186-3189	for	_
15-134	3190-3198	Children	_
15-135	3199-3207	–version	_
15-136	3208-3211	4.0	_
15-137	3212-3213	,	_
15-138	3214-3218	head	_
15-139	3219-3225	trauma	_
15-140	3226-3228	or	_
15-141	3229-3233	loss	_
15-142	3234-3236	of	_
15-143	3237-3250	consciousness	_
15-144	3251-3252	(	_
15-145	3253-3254	>	_
15-146	3255-3256	2	_
15-147	3257-3264	minutes	_
15-148	3265-3266	)	_
15-149	3267-3268	,	_
15-150	3269-3276	chronic	_
15-151	3277-3284	medical	_
15-152	3285-3292	illness	_
15-153	3293-3294	,	_
15-154	3295-3303	learning	_
15-155	3304-3314	disability	_
15-156	3315-3317	or	_
15-157	3318-3324	mental	_
15-158	3325-3336	retardation	_
15-159	3337-3338	,	_
15-160	3339-3341	or	_
15-161	3342-3345	use	_
15-162	3346-3348	of	_
15-163	3349-3360	medications	_
15-164	3361-3372	potentially	_
15-165	3373-3382	affecting	_
15-166	3383-3386	the	_
15-167	3387-3392	brain	_
15-168	3393-3394	;	_
15-169	3395-3411	contraindication	_
15-170	3412-3414	to	_
15-171	3415-3418	MRI	_
15-172	3419-3420	(	_
15-173	3421-3425	e.g.	_
15-174	3426-3427	,	_
15-175	3428-3434	braces	_
15-176	3435-3436	)	_
15-177	3437-3438	;	_
15-178	3439-3449	inadequate	_
15-179	3450-3463	comprehension	_
15-180	3464-3466	of	_
15-181	3467-3474	English	_
15-182	3475-3476	;	_
15-183	3477-3480	and	_
15-184	3481-3496	non-correctable	_
15-185	3497-3504	sensory	_
15-186	3505-3513	problems	_
15-187	3514-3515	.	_

Text=Measures Substance use measures At baseline and follow-ups, the Customary Drinking and Drug Use Record was administered to obtain quantity and frequency of lifetime and recent (past year) alcohol, marijuana, and other drug use, withdrawal/hangover symptoms, and DSM-IV abuse and dependence criteria.
16-1	3516-3524	Measures	_
16-2	3525-3534	Substance	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorder
16-3	3535-3538	use	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorder
16-4	3539-3547	measures	_
16-5	3548-3550	At	_
16-6	3551-3559	baseline	_
16-7	3560-3563	and	_
16-8	3564-3574	follow-ups	_
16-9	3575-3576	,	_
16-10	3577-3580	the	_
16-11	3581-3590	Customary	http://maven.renci.org/NeuroBridge/neurobridge#DissociativeDrugHarmfulUse
16-12	3591-3599	Drinking	http://maven.renci.org/NeuroBridge/neurobridge#DissociativeDrugHarmfulUse
16-13	3600-3603	and	http://maven.renci.org/NeuroBridge/neurobridge#DissociativeDrugHarmfulUse
16-14	3604-3608	Drug	http://maven.renci.org/NeuroBridge/neurobridge#DissociativeDrugHarmfulUse
16-15	3609-3612	Use	http://maven.renci.org/NeuroBridge/neurobridge#DissociativeDrugHarmfulUse
16-16	3613-3619	Record	http://maven.renci.org/NeuroBridge/neurobridge#DissociativeDrugHarmfulUse
16-17	3620-3623	was	_
16-18	3624-3636	administered	_
16-19	3637-3639	to	_
16-20	3640-3646	obtain	_
16-21	3647-3655	quantity	_
16-22	3656-3659	and	_
16-23	3660-3669	frequency	_
16-24	3670-3672	of	_
16-25	3673-3681	lifetime	_
16-26	3682-3685	and	_
16-27	3686-3692	recent	_
16-28	3693-3694	(	_
16-29	3695-3699	past	_
16-30	3700-3704	year	_
16-31	3705-3706	)	_
16-32	3707-3714	alcohol	_
16-33	3715-3716	,	_
16-34	3717-3726	marijuana	_
16-35	3727-3728	,	_
16-36	3729-3732	and	_
16-37	3733-3738	other	_
16-38	3739-3743	drug	_
16-39	3744-3747	use	_
16-40	3748-3749	,	_
16-41	3750-3769	withdrawal/hangover	_
16-42	3770-3778	symptoms	_
16-43	3779-3780	,	_
16-44	3781-3784	and	_
16-45	3785-3791	DSM-IV	_
16-46	3792-3797	abuse	_
16-47	3798-3801	and	_
16-48	3802-3812	dependence	_
16-49	3813-3821	criteria	_
16-50	3822-3823	.	_

Text=Breathalyzer and urine toxicology screens confirmed self-report data at baseline.
17-1	3824-3836	Breathalyzer	_
17-2	3837-3840	and	_
17-3	3841-3846	urine	_
17-4	3847-3857	toxicology	_
17-5	3858-3865	screens	_
17-6	3866-3875	confirmed	_
17-7	3876-3887	self-report	_
17-8	3888-3892	data	_
17-9	3893-3895	at	_
17-10	3896-3904	baseline	_
17-11	3905-3906	.	_

Text=Substance use information was updated every six months via phone or in-person after the participant ’ s baseline assessment.
18-1	3907-3916	Substance	_
18-2	3917-3920	use	_
18-3	3921-3932	information	_
18-4	3933-3936	was	_
18-5	3937-3944	updated	_
18-6	3945-3950	every	_
18-7	3951-3954	six	_
18-8	3955-3961	months	_
18-9	3962-3965	via	_
18-10	3966-3971	phone	_
18-11	3972-3974	or	_
18-12	3975-3984	in-person	_
18-13	3985-3990	after	_
18-14	3991-3994	the	_
18-15	3995-4006	participant	_
18-16	4007-4008	’	_
18-17	4009-4010	s	_
18-18	4011-4019	baseline	_
18-19	4020-4030	assessment	_
18-20	4031-4032	.	_

Text=Parent and/or informant (sibling, friend, roommate) report of youth substance use was collected as collateral evidence.
19-1	4033-4039	Parent	_
19-2	4040-4046	and/or	_
19-3	4047-4056	informant	_
19-4	4057-4058	(	_
19-5	4059-4066	sibling	_
19-6	4067-4068	,	_
19-7	4069-4075	friend	_
19-8	4076-4077	,	_
19-9	4078-4086	roommate	_
19-10	4087-4088	)	_
19-11	4089-4095	report	_
19-12	4096-4098	of	_
19-13	4099-4104	youth	_
19-14	4105-4114	substance	_
19-15	4115-4118	use	_
19-16	4119-4122	was	_
19-17	4123-4132	collected	_
19-18	4133-4135	as	_
19-19	4136-4146	collateral	_
19-20	4147-4155	evidence	_
19-21	4156-4157	.	_

Text=Demographic information The Structured Clinical Interview was administered to youth and ascertained information about the child ’ s sex, age, race, academic functioning (i.e., grade point average; GPA on a 4.0 scale), grade in school, family characteristics (i.e., birth order, living situation, parent ’ s marital status), dating status (e.g., never dated vs. history of dating), involvement in extracurricular activities, and hours of video games played per week.
20-1	4158-4169	Demographic	_
20-2	4170-4181	information	_
20-3	4182-4185	The	_
20-4	4186-4196	Structured	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
20-5	4197-4205	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
20-6	4206-4215	Interview	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
20-7	4216-4219	was	_
20-8	4220-4232	administered	_
20-9	4233-4235	to	_
20-10	4236-4241	youth	_
20-11	4242-4245	and	_
20-12	4246-4257	ascertained	_
20-13	4258-4269	information	_
20-14	4270-4275	about	_
20-15	4276-4279	the	_
20-16	4280-4285	child	_
20-17	4286-4287	’	_
20-18	4288-4289	s	_
20-19	4290-4293	sex	_
20-20	4294-4295	,	_
20-21	4296-4299	age	_
20-22	4300-4301	,	_
20-23	4302-4306	race	_
20-24	4307-4308	,	_
20-25	4309-4317	academic	_
20-26	4318-4329	functioning	_
20-27	4330-4331	(	_
20-28	4332-4336	i.e.	_
20-29	4337-4338	,	_
20-30	4339-4344	grade	_
20-31	4345-4350	point	_
20-32	4351-4358	average	_
20-33	4359-4360	;	_
20-34	4361-4364	GPA	_
20-35	4365-4367	on	_
20-36	4368-4369	a	_
20-37	4370-4373	4.0	_
20-38	4374-4379	scale	_
20-39	4380-4381	)	_
20-40	4382-4383	,	_
20-41	4384-4389	grade	_
20-42	4390-4392	in	_
20-43	4393-4399	school	_
20-44	4400-4401	,	_
20-45	4402-4408	family	_
20-46	4409-4424	characteristics	_
20-47	4425-4426	(	_
20-48	4427-4431	i.e.	_
20-49	4432-4433	,	_
20-50	4434-4439	birth	_
20-51	4440-4445	order	_
20-52	4446-4447	,	_
20-53	4448-4454	living	_
20-54	4455-4464	situation	_
20-55	4465-4466	,	_
20-56	4467-4473	parent	_
20-57	4474-4475	’	_
20-58	4476-4477	s	_
20-59	4478-4485	marital	_
20-60	4486-4492	status	_
20-61	4493-4494	)	_
20-62	4495-4496	,	_
20-63	4497-4503	dating	_
20-64	4504-4510	status	_
20-65	4511-4512	(	_
20-66	4513-4517	e.g.	_
20-67	4518-4519	,	_
20-68	4520-4525	never	_
20-69	4526-4531	dated	_
20-70	4532-4535	vs.	_
20-71	4536-4543	history	_
20-72	4544-4546	of	_
20-73	4547-4553	dating	_
20-74	4554-4555	)	_
20-75	4556-4557	,	_
20-76	4558-4569	involvement	_
20-77	4570-4572	in	_
20-78	4573-4588	extracurricular	_
20-79	4589-4599	activities	_
20-80	4600-4601	,	_
20-81	4602-4605	and	_
20-82	4606-4611	hours	_
20-83	4612-4614	of	_
20-84	4615-4620	video	_
20-85	4621-4626	games	_
20-86	4627-4633	played	_
20-87	4634-4637	per	_
20-88	4638-4642	week	_
20-89	4643-4644	.	_

Text=Socioeconomic status Socioeconomic background information (i.e., educational attainment, occupation, and salary of each parent) was obtained from parents and converted to a Hollingshead Index of Social Position score.
21-1	4645-4658	Socioeconomic	_
21-2	4659-4665	status	_
21-3	4666-4679	Socioeconomic	_
21-4	4680-4690	background	_
21-5	4691-4702	information	_
21-6	4703-4704	(	_
21-7	4705-4709	i.e.	_
21-8	4710-4711	,	_
21-9	4712-4723	educational	_
21-10	4724-4734	attainment	_
21-11	4735-4736	,	_
21-12	4737-4747	occupation	_
21-13	4748-4749	,	_
21-14	4750-4753	and	_
21-15	4754-4760	salary	_
21-16	4761-4763	of	_
21-17	4764-4768	each	_
21-18	4769-4775	parent	_
21-19	4776-4777	)	_
21-20	4778-4781	was	_
21-21	4782-4790	obtained	_
21-22	4791-4795	from	_
21-23	4796-4803	parents	_
21-24	4804-4807	and	_
21-25	4808-4817	converted	_
21-26	4818-4820	to	_
21-27	4821-4822	a	_
21-28	4823-4835	Hollingshead	http://maven.renci.org/NeuroBridge/neurobridge#PathologicalGambling
21-29	4836-4841	Index	_
21-30	4842-4844	of	_
21-31	4845-4851	Social	_
21-32	4852-4860	Position	_
21-33	4861-4866	score	_
21-34	4867-4868	.	_

Text=Family background At baseline, the Family History Assessment Module was administered to parents and youth and ascertained familial density of alcohol and drug use disorders in first- and second-degree relatives.
22-1	4869-4875	Family	_
22-2	4876-4886	background	_
22-3	4887-4889	At	_
22-4	4890-4898	baseline	_
22-5	4899-4900	,	_
22-6	4901-4904	the	_
22-7	4905-4911	Family	_
22-8	4912-4919	History	_
22-9	4920-4930	Assessment	_
22-10	4931-4937	Module	_
22-11	4938-4941	was	_
22-12	4942-4954	administered	_
22-13	4955-4957	to	_
22-14	4958-4965	parents	_
22-15	4966-4969	and	_
22-16	4970-4975	youth	_
22-17	4976-4979	and	_
22-18	4980-4991	ascertained	_
22-19	4992-5000	familial	_
22-20	5001-5008	density	_
22-21	5009-5011	of	_
22-22	5012-5019	alcohol	_
22-23	5020-5023	and	_
22-24	5024-5028	drug	_
22-25	5029-5032	use	_
22-26	5033-5042	disorders	_
22-27	5043-5045	in	_
22-28	5046-5052	first-	_
22-29	5053-5056	and	_
22-30	5057-5070	second-degree	_
22-31	5071-5080	relatives	_
22-32	5081-5082	.	_

Text=Family history density scores were calculated by adding 0.5 for each biological parent and 0.25 per biological grandparent endorsed by either youth or parent as having AUD or SUD for a possible score of 0 to 4.
23-1	5083-5089	Family	_
23-2	5090-5097	history	_
23-3	5098-5105	density	_
23-4	5106-5112	scores	_
23-5	5113-5117	were	_
23-6	5118-5128	calculated	_
23-7	5129-5131	by	_
23-8	5132-5138	adding	_
23-9	5139-5142	0.5	_
23-10	5143-5146	for	_
23-11	5147-5151	each	_
23-12	5152-5162	biological	_
23-13	5163-5169	parent	_
23-14	5170-5173	and	_
23-15	5174-5178	0.25	_
23-16	5179-5182	per	_
23-17	5183-5193	biological	_
23-18	5194-5205	grandparent	_
23-19	5206-5214	endorsed	_
23-20	5215-5217	by	_
23-21	5218-5224	either	_
23-22	5225-5230	youth	_
23-23	5231-5233	or	_
23-24	5234-5240	parent	_
23-25	5241-5243	as	_
23-26	5244-5250	having	_
23-27	5251-5254	AUD	_
23-28	5255-5257	or	_
23-29	5258-5261	SUD	_
23-30	5262-5265	for	_
23-31	5266-5267	a	_
23-32	5268-5276	possible	_
23-33	5277-5282	score	_
23-34	5283-5285	of	_
23-35	5286-5287	0	_
23-36	5288-5290	to	_
23-37	5291-5292	4	_
23-38	5293-5294	.	_

Text=Pubertal Development The Pubertal Development Scale ascertained current level of pubertal development for girls and boys separately with five sex-specific items, with scores ranging from 1 (prepubertal) to 4 (postpubertal).
24-1	5295-5303	Pubertal	_
24-2	5304-5315	Development	http://maven.renci.org/NeuroBridge/neurobridge#MixedDisorderofPsychologicalDevelopment
24-3	5316-5319	The	http://maven.renci.org/NeuroBridge/neurobridge#MixedDisorderofPsychologicalDevelopment
24-4	5320-5328	Pubertal	http://maven.renci.org/NeuroBridge/neurobridge#MixedDisorderofPsychologicalDevelopment
24-5	5329-5340	Development	http://maven.renci.org/NeuroBridge/neurobridge#MixedDisorderofPsychologicalDevelopment
24-6	5341-5346	Scale	http://maven.renci.org/NeuroBridge/neurobridge#MixedDisorderofPsychologicalDevelopment
24-7	5347-5358	ascertained	_
24-8	5359-5366	current	_
24-9	5367-5372	level	_
24-10	5373-5375	of	_
24-11	5376-5384	pubertal	_
24-12	5385-5396	development	_
24-13	5397-5400	for	_
24-14	5401-5406	girls	_
24-15	5407-5410	and	_
24-16	5411-5415	boys	_
24-17	5416-5426	separately	_
24-18	5427-5431	with	_
24-19	5432-5436	five	_
24-20	5437-5449	sex-specific	_
24-21	5450-5455	items	_
24-22	5456-5457	,	_
24-23	5458-5462	with	_
24-24	5463-5469	scores	_
24-25	5470-5477	ranging	_
24-26	5478-5482	from	_
24-27	5483-5484	1	_
24-28	5485-5486	(	_
24-29	5487-5498	prepubertal	_
24-30	5499-5500	)	_
24-31	5501-5503	to	_
24-32	5504-5505	4	_
24-33	5506-5507	(	_
24-34	5508-5520	postpubertal	_
24-35	5521-5522	)	_
24-36	5523-5524	.	_

Text=Participants in this sample were, on average early-to mid-pubertal at baseline, and late- to post-pubertal at follow-up.
25-1	5525-5537	Participants	_
25-2	5538-5540	in	_
25-3	5541-5545	this	_
25-4	5546-5552	sample	_
25-5	5553-5557	were	_
25-6	5558-5559	,	_
25-7	5560-5562	on	_
25-8	5563-5570	average	_
25-9	5571-5579	early-to	_
25-10	5580-5592	mid-pubertal	_
25-11	5593-5595	at	_
25-12	5596-5604	baseline	_
25-13	5605-5606	,	_
25-14	5607-5610	and	_
25-15	5611-5616	late-	_
25-16	5617-5619	to	_
25-17	5620-5633	post-pubertal	_
25-18	5634-5636	at	_
25-19	5637-5646	follow-up	_
25-20	5647-5648	.	_

Text=Psychopathology and mood The parent-administered Child Behavior Checklist (CBCL; provided age- and gender-normed continuous measures of externalizing and internalizing psychopathology.
26-1	5649-5664	Psychopathology	_
26-2	5665-5668	and	_
26-3	5669-5673	mood	_
26-4	5674-5677	The	_
26-5	5678-5697	parent-administered	_
26-6	5698-5703	Child	http://maven.renci.org/NeuroBridge/neurobridge#DisruptiveBehaviorDisorder
26-7	5704-5712	Behavior	http://maven.renci.org/NeuroBridge/neurobridge#DisruptiveBehaviorDisorder
26-8	5713-5722	Checklist	http://maven.renci.org/NeuroBridge/neurobridge#DisruptiveBehaviorDisorder
26-9	5723-5724	(	http://maven.renci.org/NeuroBridge/neurobridge#DisruptiveBehaviorDisorder
26-10	5725-5729	CBCL	http://maven.renci.org/NeuroBridge/neurobridge#DisruptiveBehaviorDisorder
26-11	5730-5731	;	_
26-12	5732-5740	provided	_
26-13	5741-5745	age-	_
26-14	5746-5749	and	_
26-15	5750-5763	gender-normed	_
26-16	5764-5774	continuous	_
26-17	5775-5783	measures	_
26-18	5784-5786	of	_
26-19	5787-5800	externalizing	_
26-20	5801-5804	and	_
26-21	5805-5818	internalizing	_
26-22	5819-5834	psychopathology	_
26-23	5835-5836	.	_

Text=T-scores from the following CBCL subscales were used in analyses: withdrawn, somatic complaints, anxious/depressed, social problems, thought problems, attention problems, delinquent behavior, aggressive behavior scores, and three summary score representing externalizing, internalizing, and total problems.
27-1	5837-5845	T-scores	_
27-2	5846-5850	from	_
27-3	5851-5854	the	_
27-4	5855-5864	following	_
27-5	5865-5869	CBCL	_
27-6	5870-5879	subscales	_
27-7	5880-5884	were	_
27-8	5885-5889	used	_
27-9	5890-5892	in	_
27-10	5893-5901	analyses	_
27-11	5902-5903	:	_
27-12	5904-5913	withdrawn	_
27-13	5914-5915	,	_
27-14	5916-5923	somatic	_
27-15	5924-5934	complaints	_
27-16	5935-5936	,	_
27-17	5937-5954	anxious/depressed	_
27-18	5955-5956	,	_
27-19	5957-5963	social	_
27-20	5964-5972	problems	_
27-21	5973-5974	,	_
27-22	5975-5982	thought	_
27-23	5983-5991	problems	_
27-24	5992-5993	,	_
27-25	5994-6003	attention	_
27-26	6004-6012	problems	_
27-27	6013-6014	,	_
27-28	6015-6025	delinquent	_
27-29	6026-6034	behavior	_
27-30	6035-6036	,	_
27-31	6037-6047	aggressive	_
27-32	6048-6056	behavior	_
27-33	6057-6063	scores	_
27-34	6064-6065	,	_
27-35	6066-6069	and	_
27-36	6070-6075	three	_
27-37	6076-6083	summary	_
27-38	6084-6089	score	_
27-39	6090-6102	representing	_
27-40	6103-6116	externalizing	_
27-41	6117-6118	,	_
27-42	6119-6132	internalizing	_
27-43	6133-6134	,	_
27-44	6135-6138	and	_
27-45	6139-6144	total	_
27-46	6145-6153	problems	_
27-47	6154-6155	.	_

Text=Youth completed the Conduct Disorder Questionnaire, which determined DSM-IV diagnostic criteria for conduct disorder; total symptom count was used in analyses.
28-1	6156-6161	Youth	_
28-2	6162-6171	completed	_
28-3	6172-6175	the	_
28-4	6176-6183	Conduct	http://maven.renci.org/NeuroBridge/neurobridge#ConductDisorder
28-5	6184-6192	Disorder	http://maven.renci.org/NeuroBridge/neurobridge#ConductDisorder
28-6	6193-6206	Questionnaire	http://maven.renci.org/NeuroBridge/neurobridge#ConductDisorder
28-7	6207-6208	,	_
28-8	6209-6214	which	_
28-9	6215-6225	determined	_
28-10	6226-6232	DSM-IV	_
28-11	6233-6243	diagnostic	_
28-12	6244-6252	criteria	_
28-13	6253-6256	for	_
28-14	6257-6264	conduct	_
28-15	6265-6273	disorder	_
28-16	6274-6275	;	_
28-17	6276-6281	total	_
28-18	6282-6289	symptom	_
28-19	6290-6295	count	_
28-20	6296-6299	was	_
28-21	6300-6304	used	_
28-22	6305-6307	in	_
28-23	6308-6316	analyses	_
28-24	6317-6318	.	_

Text=Beck Depression Inventory-II (BDI-II; and State-Trait Anxiety Inventory (STAI; assessed recent depressive and anxiety state symptoms in youth.
29-1	6319-6323	Beck	http://maven.renci.org/NeuroBridge/neurobridge#BeckDepressionInventory
29-2	6324-6334	Depression	http://maven.renci.org/NeuroBridge/neurobridge#BeckDepressionInventory
29-3	6335-6347	Inventory-II	http://maven.renci.org/NeuroBridge/neurobridge#BeckDepressionInventory
29-4	6348-6349	(	_
29-5	6350-6356	BDI-II	_
29-6	6357-6358	;	_
29-7	6359-6362	and	_
29-8	6363-6374	State-Trait	http://maven.renci.org/NeuroBridge/neurobridge#TraitAnxietyInventory
29-9	6375-6382	Anxiety	http://maven.renci.org/NeuroBridge/neurobridge#TraitAnxietyInventory
29-10	6383-6392	Inventory	http://maven.renci.org/NeuroBridge/neurobridge#TraitAnxietyInventory
29-11	6393-6394	(	http://maven.renci.org/NeuroBridge/neurobridge#TraitAnxietyInventory
29-12	6395-6399	STAI	http://maven.renci.org/NeuroBridge/neurobridge#TraitAnxietyInventory
29-13	6400-6401	;	_
29-14	6402-6410	assessed	_
29-15	6411-6417	recent	_
29-16	6418-6428	depressive	_
29-17	6429-6432	and	_
29-18	6433-6440	anxiety	_
29-19	6441-6446	state	_
29-20	6447-6455	symptoms	_
29-21	6456-6458	in	_
29-22	6459-6464	youth	_
29-23	6465-6466	.	_

Text=Alcohol Expectancy Questionnaire-Adolescent Version Youth completed the Alcohol Expectancy Questionnaire-Adolescent version (AEQ-A, which was developed to assess beliefs about the anticipated effects of alcohol.
30-1	6467-6474	Alcohol	http://maven.renci.org/NeuroBridge/neurobridge#DataCollectionInstrument
30-2	6475-6485	Expectancy	http://maven.renci.org/NeuroBridge/neurobridge#DataCollectionInstrument
30-3	6486-6510	Questionnaire-Adolescent	http://maven.renci.org/NeuroBridge/neurobridge#DataCollectionInstrument
30-4	6511-6518	Version	http://maven.renci.org/NeuroBridge/neurobridge#DataCollectionInstrument
30-5	6519-6524	Youth	_
30-6	6525-6534	completed	_
30-7	6535-6538	the	_
30-8	6539-6546	Alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseQuestionnaire
30-9	6547-6557	Expectancy	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseQuestionnaire
30-10	6558-6582	Questionnaire-Adolescent	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseQuestionnaire
30-11	6583-6590	version	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseQuestionnaire
30-12	6591-6592	(	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseQuestionnaire
30-13	6593-6598	AEQ-A	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseQuestionnaire
30-14	6599-6600	,	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseQuestionnaire
30-15	6601-6606	which	_
30-16	6607-6610	was	_
30-17	6611-6620	developed	_
30-18	6621-6623	to	_
30-19	6624-6630	assess	_
30-20	6631-6638	beliefs	_
30-21	6639-6644	about	_
30-22	6645-6648	the	_
30-23	6649-6660	anticipated	_
30-24	6661-6668	effects	_
30-25	6669-6671	of	_
30-26	6672-6679	alcohol	_
30-27	6680-6681	.	_

Text=This version yields a total score (AEQ Total Score) and seven empirically derived factor scores indicating expectations for the effects of drinking alcohol including: (1) global positive changes (AEQ Global Positive), (2) enhancement/impedance of social behavior (AEQ Social Behavior Change), (3) improvement in cognitive/behavioral functioning (AE Q Improved Performance), (4) enhancement of sexuality (AEQ Sexual Enhancement), (5) deterioration in cognitive/behavioral functioning (AEQ Impaired Performance), (6) increased arousal, (AEQ Increased Arousal) and (7) promotion of relaxation/tension reduction (AEQ Relaxation).
31-1	6682-6686	This	_
31-2	6687-6694	version	_
31-3	6695-6701	yields	_
31-4	6702-6703	a	_
31-5	6704-6709	total	_
31-6	6710-6715	score	_
31-7	6716-6717	(	_
31-8	6718-6721	AEQ	_
31-9	6722-6727	Total	_
31-10	6728-6733	Score	_
31-11	6734-6735	)	_
31-12	6736-6739	and	_
31-13	6740-6745	seven	_
31-14	6746-6757	empirically	_
31-15	6758-6765	derived	_
31-16	6766-6772	factor	_
31-17	6773-6779	scores	_
31-18	6780-6790	indicating	_
31-19	6791-6803	expectations	_
31-20	6804-6807	for	_
31-21	6808-6811	the	_
31-22	6812-6819	effects	_
31-23	6820-6822	of	_
31-24	6823-6831	drinking	_
31-25	6832-6839	alcohol	_
31-26	6840-6849	including	_
31-27	6850-6851	:	_
31-28	6852-6853	(	_
31-29	6854-6855	1	_
31-30	6856-6857	)	_
31-31	6858-6864	global	_
31-32	6865-6873	positive	_
31-33	6874-6881	changes	_
31-34	6882-6883	(	_
31-35	6884-6887	AEQ	_
31-36	6888-6894	Global	_
31-37	6895-6903	Positive	_
31-38	6904-6905	)	_
31-39	6906-6907	,	_
31-40	6908-6909	(	_
31-41	6910-6911	2	_
31-42	6912-6913	)	_
31-43	6914-6935	enhancement/impedance	_
31-44	6936-6938	of	_
31-45	6939-6945	social	_
31-46	6946-6954	behavior	_
31-47	6955-6956	(	_
31-48	6957-6960	AEQ	_
31-49	6961-6967	Social	_
31-50	6968-6976	Behavior	_
31-51	6977-6983	Change	_
31-52	6984-6985	)	_
31-53	6986-6987	,	_
31-54	6988-6989	(	_
31-55	6990-6991	3	_
31-56	6992-6993	)	_
31-57	6994-7005	improvement	_
31-58	7006-7008	in	_
31-59	7009-7029	cognitive/behavioral	_
31-60	7030-7041	functioning	_
31-61	7042-7043	(	_
31-62	7044-7046	AE	_
31-63	7047-7048	Q	_
31-64	7049-7057	Improved	_
31-65	7058-7069	Performance	_
31-66	7070-7071	)	_
31-67	7072-7073	,	_
31-68	7074-7075	(	_
31-69	7076-7077	4	_
31-70	7078-7079	)	_
31-71	7080-7091	enhancement	_
31-72	7092-7094	of	_
31-73	7095-7104	sexuality	_
31-74	7105-7106	(	_
31-75	7107-7110	AEQ	_
31-76	7111-7117	Sexual	_
31-77	7118-7129	Enhancement	_
31-78	7130-7131	)	_
31-79	7132-7133	,	_
31-80	7134-7135	(	_
31-81	7136-7137	5	_
31-82	7138-7139	)	_
31-83	7140-7153	deterioration	_
31-84	7154-7156	in	_
31-85	7157-7177	cognitive/behavioral	_
31-86	7178-7189	functioning	_
31-87	7190-7191	(	_
31-88	7192-7195	AEQ	_
31-89	7196-7204	Impaired	_
31-90	7205-7216	Performance	_
31-91	7217-7218	)	_
31-92	7219-7220	,	_
31-93	7221-7222	(	_
31-94	7223-7224	6	_
31-95	7225-7226	)	_
31-96	7227-7236	increased	_
31-97	7237-7244	arousal	_
31-98	7245-7246	,	_
31-99	7247-7248	(	_
31-100	7249-7252	AEQ	_
31-101	7253-7262	Increased	_
31-102	7263-7270	Arousal	_
31-103	7271-7272	)	_
31-104	7273-7276	and	_
31-105	7277-7278	(	_
31-106	7279-7280	7	_
31-107	7281-7282	)	_
31-108	7283-7292	promotion	_
31-109	7293-7295	of	_
31-110	7296-7314	relaxation/tension	_
31-111	7315-7324	reduction	_
31-112	7325-7326	(	_
31-113	7327-7330	AEQ	_
31-114	7331-7341	Relaxation	_
31-115	7342-7343	)	_
31-116	7344-7345	.	_

Text=Neurocognition A comprehensive neuropsychological battery was completed by youth at baseline to assess cognitive functioning on several cognitive domains that could potentially affect initiation of alcohol and marijuana use during adolescence.
32-1	7346-7360	Neurocognition	_
32-2	7361-7362	A	_
32-3	7363-7376	comprehensive	_
32-4	7377-7395	neuropsychological	_
32-5	7396-7403	battery	_
32-6	7404-7407	was	_
32-7	7408-7417	completed	_
32-8	7418-7420	by	_
32-9	7421-7426	youth	_
32-10	7427-7429	at	_
32-11	7430-7438	baseline	_
32-12	7439-7441	to	_
32-13	7442-7448	assess	_
32-14	7449-7458	cognitive	_
32-15	7459-7470	functioning	_
32-16	7471-7473	on	_
32-17	7474-7481	several	_
32-18	7482-7491	cognitive	_
32-19	7492-7499	domains	_
32-20	7500-7504	that	_
32-21	7505-7510	could	_
32-22	7511-7522	potentially	_
32-23	7523-7529	affect	_
32-24	7530-7540	initiation	_
32-25	7541-7543	of	_
32-26	7544-7551	alcohol	_
32-27	7552-7555	and	_
32-28	7556-7565	marijuana	_
32-29	7566-7569	use	_
32-30	7570-7576	during	_
32-31	7577-7588	adolescence	_
32-32	7589-7590	.	_

Text=See Table 1 for neuropsychological test and domains assessed and Supplementary References for neuropsychological testing material citations.
33-1	7591-7594	See	_
33-2	7595-7600	Table	_
33-3	7601-7602	1	_
33-4	7603-7606	for	_
33-5	7607-7625	neuropsychological	_
33-6	7626-7630	test	_
33-7	7631-7634	and	_
33-8	7635-7642	domains	_
33-9	7643-7651	assessed	_
33-10	7652-7655	and	_
33-11	7656-7669	Supplementary	_
33-12	7670-7680	References	_
33-13	7681-7684	for	_
33-14	7685-7703	neuropsychological	_
33-15	7704-7711	testing	_
33-16	7712-7720	material	_
33-17	7721-7730	citations	_
33-18	7731-7732	.	_

Text=Follow-up procedures At baseline, 12 to 14 year old youth were administered a baseline interview, neuropsychological testing, and structural and functional neuroimaging session.
34-1	7733-7742	Follow-up	_
34-2	7743-7753	procedures	_
34-3	7754-7756	At	_
34-4	7757-7765	baseline	_
34-5	7766-7767	,	_
34-6	7768-7770	12	_
34-7	7771-7773	to	_
34-8	7774-7776	14	_
34-9	7777-7781	year	_
34-10	7782-7785	old	_
34-11	7786-7791	youth	_
34-12	7792-7796	were	_
34-13	7797-7809	administered	_
34-14	7810-7811	a	_
34-15	7812-7820	baseline	_
34-16	7821-7830	interview	_
34-17	7831-7832	,	_
34-18	7833-7851	neuropsychological	_
34-19	7852-7859	testing	_
34-20	7860-7861	,	_
34-21	7862-7865	and	_
34-22	7866-7876	structural	_
34-23	7877-7880	and	_
34-24	7881-7891	functional	_
34-25	7892-7904	neuroimaging	_
34-26	7905-7912	session	_
34-27	7913-7914	.	_

Text=Every 6 months, over-the-phone or in-person interviews assessed current substance use and psychiatric functioning.
35-1	7915-7920	Every	_
35-2	7921-7922	6	_
35-3	7923-7929	months	_
35-4	7930-7931	,	_
35-5	7932-7946	over-the-phone	_
35-6	7947-7949	or	_
35-7	7950-7959	in-person	_
35-8	7960-7970	interviews	_
35-9	7971-7979	assessed	_
35-10	7980-7987	current	_
35-11	7988-7997	substance	_
35-12	7998-8001	use	_
35-13	8002-8005	and	_
35-14	8006-8017	psychiatric	_
35-15	8018-8029	functioning	_
35-16	8030-8031	.	_

Text=At baseline, all participants were considered controls, and had never had more than 10 lifetime alcohol use occasions, with never more than 1 drink per occasion, and no more than 3 lifetime marijuana use episodes.
36-1	8032-8034	At	_
36-2	8035-8043	baseline	_
36-3	8044-8045	,	_
36-4	8046-8049	all	_
36-5	8050-8062	participants	_
36-6	8063-8067	were	_
36-7	8068-8078	considered	_
36-8	8079-8087	controls	_
36-9	8088-8089	,	_
36-10	8090-8093	and	_
36-11	8094-8097	had	_
36-12	8098-8103	never	_
36-13	8104-8107	had	_
36-14	8108-8112	more	_
36-15	8113-8117	than	_
36-16	8118-8120	10	_
36-17	8121-8129	lifetime	_
36-18	8130-8137	alcohol	_
36-19	8138-8141	use	_
36-20	8142-8151	occasions	_
36-21	8152-8153	,	_
36-22	8154-8158	with	_
36-23	8159-8164	never	_
36-24	8165-8169	more	_
36-25	8170-8174	than	_
36-26	8175-8176	1	_
36-27	8177-8182	drink	_
36-28	8183-8186	per	_
36-29	8187-8195	occasion	_
36-30	8196-8197	,	_
36-31	8198-8201	and	_
36-32	8202-8204	no	_
36-33	8205-8209	more	_
36-34	8210-8214	than	_
36-35	8215-8216	3	_
36-36	8217-8225	lifetime	_
36-37	8226-8235	marijuana	_
36-38	8236-8239	use	_
36-39	8240-8248	episodes	_
36-40	8249-8250	.	_

Text=Ninety-seven percent of the sample had never used alcohol and 98% had never used marijuana.
37-1	8251-8263	Ninety-seven	_
37-2	8264-8271	percent	_
37-3	8272-8274	of	_
37-4	8275-8278	the	_
37-5	8279-8285	sample	_
37-6	8286-8289	had	_
37-7	8290-8295	never	_
37-8	8296-8300	used	_
37-9	8301-8308	alcohol	_
37-10	8309-8312	and	_
37-11	8313-8315	98	_
37-12	8316-8317	%	_
37-13	8318-8321	had	_
37-14	8322-8327	never	_
37-15	8328-8332	used	_
37-16	8333-8342	marijuana	_
37-17	8343-8344	.	_

Text=Rigorous follow-up procedures were utilized to ensure excellent follow-up rates (96%).
38-1	8345-8353	Rigorous	_
38-2	8354-8363	follow-up	_
38-3	8364-8374	procedures	_
38-4	8375-8379	were	_
38-5	8380-8388	utilized	_
38-6	8389-8391	to	_
38-7	8392-8398	ensure	_
38-8	8399-8408	excellent	_
38-9	8409-8418	follow-up	_
38-10	8419-8424	rates	_
38-11	8425-8426	(	_
38-12	8427-8429	96	_
38-13	8430-8431	%	_
38-14	8432-8433	)	_
38-15	8434-8435	.	_

Text=At follow-up (age ~18), participants were classified as continuous controls (baseline control who maintained abstinence over the follow-up, defined as 0–4 drinks on an occasion and <12 lifetime drinking occasions; 61% continued to remain completely alcohol-naïve at follow-up) or moderate-heavy drinking initiators (baseline control who transitioned into moderate or heavy alcohol use, defined as 3–29 drinks on an occasion and 3–834 drinking occasions; see Figure 1 for classification).
39-1	8436-8438	At	_
39-2	8439-8448	follow-up	_
39-3	8449-8450	(	_
39-4	8451-8454	age	_
39-5	8455-8458	~18	_
39-6	8459-8460	)	_
39-7	8461-8462	,	_
39-8	8463-8475	participants	_
39-9	8476-8480	were	_
39-10	8481-8491	classified	_
39-11	8492-8494	as	_
39-12	8495-8505	continuous	_
39-13	8506-8514	controls	_
39-14	8515-8516	(	_
39-15	8517-8525	baseline	_
39-16	8526-8533	control	_
39-17	8534-8537	who	_
39-18	8538-8548	maintained	_
39-19	8549-8559	abstinence	_
39-20	8560-8564	over	_
39-21	8565-8568	the	_
39-22	8569-8578	follow-up	_
39-23	8579-8580	,	_
39-24	8581-8588	defined	_
39-25	8589-8591	as	_
39-26	8592-8595	0–4	_
39-27	8596-8602	drinks	_
39-28	8603-8605	on	_
39-29	8606-8608	an	_
39-30	8609-8617	occasion	_
39-31	8618-8621	and	_
39-32	8622-8623	<	_
39-33	8624-8626	12	_
39-34	8627-8635	lifetime	_
39-35	8636-8644	drinking	_
39-36	8645-8654	occasions	_
39-37	8655-8656	;	_
39-38	8657-8659	61	_
39-39	8660-8661	%	_
39-40	8662-8671	continued	_
39-41	8672-8674	to	_
39-42	8675-8681	remain	_
39-43	8682-8692	completely	_
39-44	8693-8706	alcohol-naïve	_
39-45	8707-8709	at	_
39-46	8710-8719	follow-up	_
39-47	8720-8721	)	_
39-48	8722-8724	or	_
39-49	8725-8739	moderate-heavy	_
39-50	8740-8748	drinking	_
39-51	8749-8759	initiators	_
39-52	8760-8761	(	_
39-53	8762-8770	baseline	_
39-54	8771-8778	control	_
39-55	8779-8782	who	_
39-56	8783-8795	transitioned	_
39-57	8796-8800	into	_
39-58	8801-8809	moderate	_
39-59	8810-8812	or	_
39-60	8813-8818	heavy	_
39-61	8819-8826	alcohol	_
39-62	8827-8830	use	_
39-63	8831-8832	,	_
39-64	8833-8840	defined	_
39-65	8841-8843	as	_
39-66	8844-8848	3–29	_
39-67	8849-8855	drinks	_
39-68	8856-8858	on	_
39-69	8859-8861	an	_
39-70	8862-8870	occasion	_
39-71	8871-8874	and	_
39-72	8875-8880	3–834	_
39-73	8881-8889	drinking	_
39-74	8890-8899	occasions	_
39-75	8900-8901	;	_
39-76	8902-8905	see	_
39-77	8906-8912	Figure	_
39-78	8913-8914	1	_
39-79	8915-8918	for	_
39-80	8919-8933	classification	_
39-81	8934-8935	)	_
39-82	8936-8937	.	_

Text=Participants who had fewer drinking days, but drank significantly on those occasions (e.g., 3 lifetime occasions, 15 drinks per occasion) were classified as moderate-heavy drinkers to capture the fact they had initiated significant levels of alcohol use.
40-1	8938-8950	Participants	_
40-2	8951-8954	who	_
40-3	8955-8958	had	_
40-4	8959-8964	fewer	_
40-5	8965-8973	drinking	_
40-6	8974-8978	days	_
40-7	8979-8980	,	_
40-8	8981-8984	but	_
40-9	8985-8990	drank	_
40-10	8991-9004	significantly	_
40-11	9005-9007	on	_
40-12	9008-9013	those	_
40-13	9014-9023	occasions	_
40-14	9024-9025	(	_
40-15	9026-9030	e.g.	_
40-16	9031-9032	,	_
40-17	9033-9034	3	_
40-18	9035-9043	lifetime	_
40-19	9044-9053	occasions	_
40-20	9054-9055	,	_
40-21	9056-9058	15	_
40-22	9059-9065	drinks	_
40-23	9066-9069	per	_
40-24	9070-9078	occasion	_
40-25	9079-9080	)	_
40-26	9081-9085	were	_
40-27	9086-9096	classified	_
40-28	9097-9099	as	_
40-29	9100-9114	moderate-heavy	_
40-30	9115-9123	drinkers	_
40-31	9124-9126	to	_
40-32	9127-9134	capture	_
40-33	9135-9138	the	_
40-34	9139-9143	fact	_
40-35	9144-9148	they	_
40-36	9149-9152	had	_
40-37	9153-9162	initiated	_
40-38	9163-9174	significant	_
40-39	9175-9181	levels	_
40-40	9182-9184	of	_
40-41	9185-9192	alcohol	_
40-42	9193-9196	use	_
40-43	9197-9198	.	_

Text=Sixty-seven participants were classified as continuous controls, while 70 (51%) were moderate-heavy drinking initiators (see Table 1; 27% met criteria for moderate drinking, while 73% met criteria for heavy drinking).
41-1	9199-9210	Sixty-seven	_
41-2	9211-9223	participants	_
41-3	9224-9228	were	_
41-4	9229-9239	classified	_
41-5	9240-9242	as	_
41-6	9243-9253	continuous	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
41-7	9254-9262	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
41-8	9263-9264	,	_
41-9	9265-9270	while	_
41-10	9271-9273	70	_
41-11	9274-9275	(	_
41-12	9276-9278	51	_
41-13	9279-9280	%	_
41-14	9281-9282	)	_
41-15	9283-9287	were	_
41-16	9288-9302	moderate-heavy	_
41-17	9303-9311	drinking	_
41-18	9312-9322	initiators	_
41-19	9323-9324	(	_
41-20	9325-9328	see	_
41-21	9329-9334	Table	_
41-22	9335-9336	1	_
41-23	9337-9338	;	_
41-24	9339-9341	27	_
41-25	9342-9343	%	_
41-26	9344-9347	met	_
41-27	9348-9356	criteria	_
41-28	9357-9360	for	_
41-29	9361-9369	moderate	_
41-30	9370-9378	drinking	_
41-31	9379-9380	,	_
41-32	9381-9386	while	_
41-33	9387-9389	73	_
41-34	9390-9391	%	_
41-35	9392-9395	met	_
41-36	9396-9404	criteria	_
41-37	9405-9408	for	_
41-38	9409-9414	heavy	_
41-39	9415-9423	drinking	_
41-40	9424-9425	)	_
41-41	9426-9427	.	_

Text=Continuous non-users were at least 17 years of age at follow-up, to allow sufficient time to transition into alcohol use.
42-1	9428-9438	Continuous	_
42-2	9439-9448	non-users	_
42-3	9449-9453	were	_
42-4	9454-9456	at	_
42-5	9457-9462	least	_
42-6	9463-9465	17	_
42-7	9466-9471	years	_
42-8	9472-9474	of	_
42-9	9475-9478	age	_
42-10	9479-9481	at	_
42-11	9482-9491	follow-up	_
42-12	9492-9493	,	_
42-13	9494-9496	to	_
42-14	9497-9502	allow	_
42-15	9503-9513	sufficient	_
42-16	9514-9518	time	_
42-17	9519-9521	to	_
42-18	9522-9532	transition	_
42-19	9533-9537	into	_
42-20	9538-9545	alcohol	_
42-21	9546-9549	use	_
42-22	9550-9551	.	_

Text=Sixteen-year-old substance users were included, as it was clear that substance use had onset by that age.
43-1	9552-9568	Sixteen-year-old	_
43-2	9569-9578	substance	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorder
43-3	9579-9584	users	http://maven.renci.org/NeuroBridge/neurobridge#SubstanceDisorder
43-4	9585-9589	were	_
43-5	9590-9598	included	_
43-6	9599-9600	,	_
43-7	9601-9603	as	_
43-8	9604-9606	it	_
43-9	9607-9610	was	_
43-10	9611-9616	clear	_
43-11	9617-9621	that	_
43-12	9622-9631	substance	_
43-13	9632-9635	use	_
43-14	9636-9639	had	_
43-15	9640-9645	onset	_
43-16	9646-9648	by	_
43-17	9649-9653	that	_
43-18	9654-9657	age	_
43-19	9658-9659	.	_

Text=For this sample, rates of alcohol initiation were consistent with the general US adolescent population.
44-1	9660-9663	For	_
44-2	9664-9668	this	_
44-3	9669-9675	sample	_
44-4	9676-9677	,	_
44-5	9678-9683	rates	_
44-6	9684-9686	of	_
44-7	9687-9694	alcohol	_
44-8	9695-9705	initiation	_
44-9	9706-9710	were	_
44-10	9711-9721	consistent	_
44-11	9722-9726	with	_
44-12	9727-9730	the	_
44-13	9731-9738	general	_
44-14	9739-9741	US	_
44-15	9742-9752	adolescent	_
44-16	9753-9763	population	_
44-17	9764-9765	.	_

Text=Procedures Image acquisition High-resolution anatomical and functional images were collected at the UC San Diego Center for fMRI on a 3-Tesla CXK4 short bore Excite-2 MR system (General Electric, Milwaukee, WI) with an 8-channel phase-array head coil.
45-1	9766-9776	Procedures	_
45-2	9777-9782	Image	_
45-3	9783-9794	acquisition	http://maven.renci.org/NeuroBridge/neurobridge#Education
45-4	9795-9810	High-resolution	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
45-5	9811-9821	anatomical	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
45-6	9822-9825	and	_
45-7	9826-9836	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
45-8	9837-9843	images	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
45-9	9844-9848	were	_
45-10	9849-9858	collected	_
45-11	9859-9861	at	_
45-12	9862-9865	the	_
45-13	9866-9868	UC	_
45-14	9869-9872	San	_
45-15	9873-9878	Diego	_
45-16	9879-9885	Center	_
45-17	9886-9889	for	_
45-18	9890-9894	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
45-19	9895-9897	on	_
45-20	9898-9899	a	_
45-21	9900-9907	3-Tesla	_
45-22	9908-9912	CXK4	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
45-23	9913-9918	short	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
45-24	9919-9923	bore	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
45-25	9924-9932	Excite-2	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
45-26	9933-9935	MR	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
45-27	9936-9942	system	_
45-28	9943-9944	(	_
45-29	9945-9952	General	_
45-30	9953-9961	Electric	_
45-31	9962-9963	,	_
45-32	9964-9973	Milwaukee	_
45-33	9974-9975	,	_
45-34	9976-9978	WI	_
45-35	9979-9980	)	_
45-36	9981-9985	with	_
45-37	9986-9988	an	_
45-38	9989-9998	8-channel	_
45-39	9999-10010	phase-array	_
45-40	10011-10015	head	_
45-41	10016-10020	coil	_
45-42	10021-10022	.	_

Text=Participants were placed comfortably on the scanner table and the head was stabilized within the head coil using foam cushions (NoMoCo, La Jolla, CA).
46-1	10023-10035	Participants	_
46-2	10036-10040	were	_
46-3	10041-10047	placed	_
46-4	10048-10059	comfortably	_
46-5	10060-10062	on	_
46-6	10063-10066	the	_
46-7	10067-10074	scanner	_
46-8	10075-10080	table	_
46-9	10081-10084	and	_
46-10	10085-10088	the	_
46-11	10089-10093	head	_
46-12	10094-10097	was	_
46-13	10098-10108	stabilized	_
46-14	10109-10115	within	_
46-15	10116-10119	the	_
46-16	10120-10124	head	_
46-17	10125-10129	coil	_
46-18	10130-10135	using	_
46-19	10136-10140	foam	_
46-20	10141-10149	cushions	_
46-21	10150-10151	(	_
46-22	10152-10158	NoMoCo	_
46-23	10159-10160	,	_
46-24	10161-10163	La	_
46-25	10164-10169	Jolla	_
46-26	10170-10171	,	_
46-27	10172-10174	CA	_
46-28	10175-10176	)	_
46-29	10177-10178	.	_

Text=Scan sessions involved a 10-second scout scan to assure good head placement and slice selection covering the whole brain followed by a high-resolution T1-weighted sequence using a sagittally-acquired spoiled gradient recalled sequence (FOV 24 cm, 256 × 256 × 192 matrix, .94 × .94 × 1 mm voxels, 176 slices, TR=20 ms, TE=4.8 ms; flip angle 12°, acquisition time 7:26 minutes).
47-1	10179-10183	Scan	_
47-2	10184-10192	sessions	_
47-3	10193-10201	involved	_
47-4	10202-10203	a	_
47-5	10204-10213	10-second	_
47-6	10214-10219	scout	_
47-7	10220-10224	scan	http://maven.renci.org/NeuroBridge/neurobridge#ComputedTomographyScan
47-8	10225-10227	to	_
47-9	10228-10234	assure	_
47-10	10235-10239	good	_
47-11	10240-10244	head	_
47-12	10245-10254	placement	_
47-13	10255-10258	and	_
47-14	10259-10264	slice	_
47-15	10265-10274	selection	_
47-16	10275-10283	covering	_
47-17	10284-10287	the	_
47-18	10288-10293	whole	_
47-19	10294-10299	brain	_
47-20	10300-10308	followed	_
47-21	10309-10311	by	_
47-22	10312-10313	a	_
47-23	10314-10329	high-resolution	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
47-24	10330-10341	T1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
47-25	10342-10350	sequence	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
47-26	10351-10356	using	_
47-27	10357-10358	a	_
47-28	10359-10378	sagittally-acquired	_
47-29	10379-10386	spoiled	_
47-30	10387-10395	gradient	_
47-31	10396-10404	recalled	_
47-32	10405-10413	sequence	_
47-33	10414-10415	(	_
47-34	10416-10419	FOV	_
47-35	10420-10422	24	_
47-36	10423-10425	cm	_
47-37	10426-10427	,	_
47-38	10428-10431	256	_
47-39	10432-10433	×	_
47-40	10434-10437	256	_
47-41	10438-10439	×	_
47-42	10440-10443	192	_
47-43	10444-10450	matrix	_
47-44	10451-10452	,	_
47-45	10453-10456	.94	_
47-46	10457-10458	×	_
47-47	10459-10462	.94	_
47-48	10463-10464	×	_
47-49	10465-10466	1	_
47-50	10467-10469	mm	_
47-51	10470-10476	voxels	_
47-52	10477-10478	,	_
47-53	10479-10482	176	_
47-54	10483-10489	slices	_
47-55	10490-10491	,	_
47-56	10492-10497	TR=20	_
47-57	10498-10500	ms	_
47-58	10501-10502	,	_
47-59	10503-10509	TE=4.8	_
47-60	10510-10512	ms	_
47-61	10513-10514	;	_
47-62	10515-10519	flip	_
47-63	10520-10525	angle	_
47-64	10526-10529	12°	_
47-65	10530-10531	,	_
47-66	10532-10543	acquisition	_
47-67	10544-10548	time	_
47-68	10549-10553	7:26	_
47-69	10554-10561	minutes	_
47-70	10562-10563	)	_
47-71	10564-10565	.	_

Text=BOLD response contrast was measured with T2 * -weighted axially acquired echo-planar images (FOV=24 cm, 64 × 64 matrix, 3.75 × 3.75 × 3.8 mm voxels, 32 slices, TE=30 ms, TR=2000 ms, flip angle 90°, ramped bandwidth 250 KHz).
48-1	10566-10570	BOLD	_
48-2	10571-10579	response	_
48-3	10580-10588	contrast	_
48-4	10589-10592	was	_
48-5	10593-10601	measured	_
48-6	10602-10606	with	_
48-7	10607-10609	T2	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
48-8	10610-10611	*	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
48-9	10612-10621	-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
48-10	10622-10629	axially	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
48-11	10630-10638	acquired	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
48-12	10639-10650	echo-planar	_
48-13	10651-10657	images	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
48-14	10658-10659	(	_
48-15	10660-10666	FOV=24	_
48-16	10667-10669	cm	_
48-17	10670-10671	,	_
48-18	10672-10674	64	_
48-19	10675-10676	×	_
48-20	10677-10679	64	_
48-21	10680-10686	matrix	_
48-22	10687-10688	,	_
48-23	10689-10693	3.75	_
48-24	10694-10695	×	_
48-25	10696-10700	3.75	_
48-26	10701-10702	×	_
48-27	10703-10706	3.8	_
48-28	10707-10709	mm	_
48-29	10710-10716	voxels	_
48-30	10717-10718	,	_
48-31	10719-10721	32	_
48-32	10722-10728	slices	_
48-33	10729-10730	,	_
48-34	10731-10736	TE=30	_
48-35	10737-10739	ms	_
48-36	10740-10741	,	_
48-37	10742-10749	TR=2000	_
48-38	10750-10752	ms	_
48-39	10753-10754	,	_
48-40	10755-10759	flip	_
48-41	10760-10765	angle	_
48-42	10766-10769	90°	_
48-43	10770-10771	,	_
48-44	10772-10778	ramped	_
48-45	10779-10788	bandwidth	_
48-46	10789-10792	250	_
48-47	10793-10796	KHz	_
48-48	10797-10798	)	_
48-49	10799-10800	.	_

Text=Field maps were acquired to minimize warping and signal dropout (~4 minutes total) and employed 2 different echo times to assess field inhomogeneities and signal distortions under the same grid parameters as echo-planar images were acquired.
49-1	10801-10806	Field	_
49-2	10807-10811	maps	_
49-3	10812-10816	were	_
49-4	10817-10825	acquired	_
49-5	10826-10828	to	_
49-6	10829-10837	minimize	_
49-7	10838-10845	warping	_
49-8	10846-10849	and	_
49-9	10850-10856	signal	_
49-10	10857-10864	dropout	_
49-11	10865-10866	(	_
49-12	10867-10869	~4	_
49-13	10870-10877	minutes	_
49-14	10878-10883	total	_
49-15	10884-10885	)	_
49-16	10886-10889	and	_
49-17	10890-10898	employed	_
49-18	10899-10900	2	_
49-19	10901-10910	different	_
49-20	10911-10915	echo	_
49-21	10916-10921	times	_
49-22	10922-10924	to	_
49-23	10925-10931	assess	_
49-24	10932-10937	field	_
49-25	10938-10953	inhomogeneities	_
49-26	10954-10957	and	_
49-27	10958-10964	signal	_
49-28	10965-10976	distortions	_
49-29	10977-10982	under	_
49-30	10983-10986	the	_
49-31	10987-10991	same	_
49-32	10992-10996	grid	_
49-33	10997-11007	parameters	_
49-34	11008-11010	as	_
49-35	11011-11022	echo-planar	_
49-36	11023-11029	images	_
49-37	11030-11034	were	_
49-38	11035-11043	acquired	_
49-39	11044-11045	.	_

Text=Visual Working Memory Task All participants were administered the same fast event related visual working memory task during fMRI acquisition, which has been shown to predict future initiation of alcohol use.
50-1	11046-11052	Visual	http://maven.renci.org/NeuroBridge/neurobridge#WorkingMemoryTask
50-2	11053-11060	Working	http://maven.renci.org/NeuroBridge/neurobridge#WorkingMemoryTask
50-3	11061-11067	Memory	http://maven.renci.org/NeuroBridge/neurobridge#WorkingMemoryTask
50-4	11068-11072	Task	http://maven.renci.org/NeuroBridge/neurobridge#WorkingMemoryTask
50-5	11073-11076	All	_
50-6	11077-11089	participants	_
50-7	11090-11094	were	_
50-8	11095-11107	administered	_
50-9	11108-11111	the	_
50-10	11112-11116	same	_
50-11	11117-11121	fast	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImagingProtocol
50-12	11122-11127	event	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImagingProtocol
50-13	11128-11135	related	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImagingProtocol
50-14	11136-11142	visual	http://maven.renci.org/NeuroBridge/neurobridge#WorkingMemoryTask
50-15	11143-11150	working	http://maven.renci.org/NeuroBridge/neurobridge#WorkingMemoryTask
50-16	11151-11157	memory	http://maven.renci.org/NeuroBridge/neurobridge#WorkingMemoryTask
50-17	11158-11162	task	http://maven.renci.org/NeuroBridge/neurobridge#WorkingMemoryTask
50-18	11163-11169	during	_
50-19	11170-11174	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
50-20	11175-11186	acquisition	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
50-21	11187-11188	,	_
50-22	11189-11194	which	_
50-23	11195-11198	has	_
50-24	11199-11203	been	_
50-25	11204-11209	shown	_
50-26	11210-11212	to	_
50-27	11213-11220	predict	_
50-28	11221-11227	future	_
50-29	11228-11238	initiation	_
50-30	11239-11241	of	_
50-31	11242-11249	alcohol	_
50-32	11250-11253	use	_
50-33	11254-11255	.	_

Text=Participants were required to indicate whether dot arrays presented with a 2000ms inter-stimulus interval were identical or differed (i.e., one dot was of a different color).
51-1	11256-11268	Participants	_
51-2	11269-11273	were	_
51-3	11274-11282	required	_
51-4	11283-11285	to	_
51-5	11286-11294	indicate	_
51-6	11295-11302	whether	_
51-7	11303-11306	dot	_
51-8	11307-11313	arrays	_
51-9	11314-11323	presented	_
51-10	11324-11328	with	_
51-11	11329-11330	a	_
51-12	11331-11337	2000ms	_
51-13	11338-11352	inter-stimulus	_
51-14	11353-11361	interval	_
51-15	11362-11366	were	_
51-16	11367-11376	identical	_
51-17	11377-11379	or	_
51-18	11380-11388	differed	_
51-19	11389-11390	(	_
51-20	11391-11395	i.e.	_
51-21	11396-11397	,	_
51-22	11398-11401	one	_
51-23	11402-11405	dot	_
51-24	11406-11409	was	_
51-25	11410-11412	of	_
51-26	11413-11414	a	_
51-27	11415-11424	different	_
51-28	11425-11430	color	_
51-29	11431-11432	)	_
51-30	11433-11434	.	_

Text=Each subject completed 30 trials of each level of complexity (2, 4, or 6 dots) presented randomly, in addition to 69 null trials of 2000 ms each interspersed to provide an optimized fast-event related sequence (256 repetitions in all; 8 minutes and 32 seconds).
52-1	11435-11439	Each	_
52-2	11440-11447	subject	_
52-3	11448-11457	completed	_
52-4	11458-11460	30	_
52-5	11461-11467	trials	_
52-6	11468-11470	of	_
52-7	11471-11475	each	_
52-8	11476-11481	level	_
52-9	11482-11484	of	_
52-10	11485-11495	complexity	_
52-11	11496-11497	(	_
52-12	11498-11499	2	_
52-13	11500-11501	,	_
52-14	11502-11503	4	_
52-15	11504-11505	,	_
52-16	11506-11508	or	_
52-17	11509-11510	6	_
52-18	11511-11515	dots	_
52-19	11516-11517	)	_
52-20	11518-11527	presented	_
52-21	11528-11536	randomly	_
52-22	11537-11538	,	_
52-23	11539-11541	in	_
52-24	11542-11550	addition	_
52-25	11551-11553	to	_
52-26	11554-11556	69	_
52-27	11557-11561	null	_
52-28	11562-11568	trials	_
52-29	11569-11571	of	_
52-30	11572-11576	2000	_
52-31	11577-11579	ms	_
52-32	11580-11584	each	_
52-33	11585-11597	interspersed	_
52-34	11598-11600	to	_
52-35	11601-11608	provide	_
52-36	11609-11611	an	_
52-37	11612-11621	optimized	_
52-38	11622-11632	fast-event	_
52-39	11633-11640	related	_
52-40	11641-11649	sequence	_
52-41	11650-11651	(	_
52-42	11652-11655	256	_
52-43	11656-11667	repetitions	_
52-44	11668-11670	in	_
52-45	11671-11674	all	_
52-46	11675-11676	;	_
52-47	11677-11678	8	_
52-48	11679-11686	minutes	_
52-49	11687-11690	and	_
52-50	11691-11693	32	_
52-51	11694-11701	seconds	_
52-52	11702-11703	)	_
52-53	11704-11705	.	_

Text=The 6-dot condition is considered supra-span (i.e., higher than most people ’ s working memory span) and the 2-dot condition is sub-span (i.e., well within most people ’ s working memory load capacity.
53-1	11706-11709	The	_
53-2	11710-11715	6-dot	_
53-3	11716-11725	condition	_
53-4	11726-11728	is	_
53-5	11729-11739	considered	_
53-6	11740-11750	supra-span	_
53-7	11751-11752	(	_
53-8	11753-11757	i.e.	_
53-9	11758-11759	,	_
53-10	11760-11766	higher	_
53-11	11767-11771	than	_
53-12	11772-11776	most	_
53-13	11777-11783	people	_
53-14	11784-11785	’	_
53-15	11786-11787	s	_
53-16	11788-11795	working	_
53-17	11796-11802	memory	_
53-18	11803-11807	span	_
53-19	11808-11809	)	_
53-20	11810-11813	and	_
53-21	11814-11817	the	_
53-22	11818-11823	2-dot	_
53-23	11824-11833	condition	_
53-24	11834-11836	is	_
53-25	11837-11845	sub-span	_
53-26	11846-11847	(	_
53-27	11848-11852	i.e.	_
53-28	11853-11854	,	_
53-29	11855-11859	well	_
53-30	11860-11866	within	_
53-31	11867-11871	most	_
53-32	11872-11878	people	_
53-33	11879-11880	’	_
53-34	11881-11882	s	_
53-35	11883-11890	working	_
53-36	11891-11897	memory	_
53-37	11898-11902	load	_
53-38	11903-11911	capacity	_
53-39	11912-11913	.	_

Text=None of the 137 total runs used during analysis had performance at or below chance level (50%) on the 2-dot (i.e., low-capacity/easy condition).
54-1	11914-11918	None	_
54-2	11919-11921	of	_
54-3	11922-11925	the	_
54-4	11926-11929	137	_
54-5	11930-11935	total	_
54-6	11936-11940	runs	_
54-7	11941-11945	used	_
54-8	11946-11952	during	_
54-9	11953-11961	analysis	_
54-10	11962-11965	had	_
54-11	11966-11977	performance	_
54-12	11978-11980	at	_
54-13	11981-11983	or	_
54-14	11984-11989	below	_
54-15	11990-11996	chance	_
54-16	11997-12002	level	_
54-17	12003-12004	(	_
54-18	12005-12007	50	_
54-19	12008-12009	%	_
54-20	12010-12011	)	_
54-21	12012-12014	on	_
54-22	12015-12018	the	_
54-23	12019-12024	2-dot	_
54-24	12025-12026	(	_
54-25	12027-12031	i.e.	_
54-26	12032-12033	,	_
54-27	12034-12051	low-capacity/easy	_
54-28	12052-12061	condition	_
54-29	12062-12063	)	_
54-30	12064-12065	.	_

Text=A greater BOLD response contrast (i.e., larger fit coefficient) to the 6-dot (supra-span) relative to the 2-dot (sub-span) condition was interpreted as more cognitive energy expended to complete the challenging supra-span trials.
55-1	12066-12067	A	_
55-2	12068-12075	greater	_
55-3	12076-12080	BOLD	_
55-4	12081-12089	response	_
55-5	12090-12098	contrast	_
55-6	12099-12100	(	_
55-7	12101-12105	i.e.	_
55-8	12106-12107	,	_
55-9	12108-12114	larger	_
55-10	12115-12118	fit	_
55-11	12119-12130	coefficient	_
55-12	12131-12132	)	_
55-13	12133-12135	to	_
55-14	12136-12139	the	_
55-15	12140-12145	6-dot	_
55-16	12146-12147	(	_
55-17	12148-12158	supra-span	_
55-18	12159-12160	)	_
55-19	12161-12169	relative	_
55-20	12170-12172	to	_
55-21	12173-12176	the	_
55-22	12177-12182	2-dot	_
55-23	12183-12184	(	_
55-24	12185-12193	sub-span	_
55-25	12194-12195	)	_
55-26	12196-12205	condition	_
55-27	12206-12209	was	_
55-28	12210-12221	interpreted	_
55-29	12222-12224	as	_
55-30	12225-12229	more	_
55-31	12230-12239	cognitive	_
55-32	12240-12246	energy	_
55-33	12247-12255	expended	_
55-34	12256-12258	to	_
55-35	12259-12267	complete	_
55-36	12268-12271	the	_
55-37	12272-12283	challenging	_
55-38	12284-12294	supra-span	_
55-39	12295-12301	trials	_
55-40	12302-12303	.	_

Text=Data Analysis Structural image processing FreeSurfer (version 5.0, surfer.nmr.mgh.harvard.edu) was used for cortical surface reconstruction and cortical thickness estimation of the high-resolution T1-weighted MR data.
56-1	12304-12308	Data	_
56-2	12309-12317	Analysis	_
56-3	12318-12328	Structural	_
56-4	12329-12334	image	_
56-5	12335-12345	processing	_
56-6	12346-12356	FreeSurfer	_
56-7	12357-12358	(	_
56-8	12359-12366	version	_
56-9	12367-12370	5.0	_
56-10	12371-12372	,	_
56-11	12373-12399	surfer.nmr.mgh.harvard.edu	_
56-12	12400-12401	)	_
56-13	12402-12405	was	_
56-14	12406-12410	used	_
56-15	12411-12414	for	_
56-16	12415-12423	cortical	_
56-17	12424-12431	surface	_
56-18	12432-12446	reconstruction	_
56-19	12447-12450	and	_
56-20	12451-12459	cortical	_
56-21	12460-12469	thickness	_
56-22	12470-12480	estimation	_
56-23	12481-12483	of	_
56-24	12484-12487	the	_
56-25	12488-12503	high-resolution	_
56-26	12504-12515	T1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
56-27	12516-12518	MR	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
56-28	12519-12523	data	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
56-29	12524-12525	.	_

Text=The FreeSurfer program utilizes a series of automated imaging algorithms to produce measures of cortical thickness.
57-1	12526-12529	The	_
57-2	12530-12540	FreeSurfer	_
57-3	12541-12548	program	_
57-4	12549-12557	utilizes	_
57-5	12558-12559	a	_
57-6	12560-12566	series	_
57-7	12567-12569	of	_
57-8	12570-12579	automated	_
57-9	12580-12587	imaging	_
57-10	12588-12598	algorithms	_
57-11	12599-12601	to	_
57-12	12602-12609	produce	_
57-13	12610-12618	measures	_
57-14	12619-12621	of	_
57-15	12622-12630	cortical	_
57-16	12631-12640	thickness	_
57-17	12641-12642	.	_

Text=One rater (LMS), blind to participant characteristics, followed the reconstruction procedures (http: //surfer.nmr.mgh.harvard.edu/fswiki/RecommendedReconstruction) to identify and correct any errors made during the cortical reconstruction.
58-1	12643-12646	One	_
58-2	12647-12652	rater	_
58-3	12653-12654	(	_
58-4	12655-12658	LMS	_
58-5	12659-12660	)	_
58-6	12661-12662	,	_
58-7	12663-12668	blind	_
58-8	12669-12671	to	_
58-9	12672-12683	participant	_
58-10	12684-12699	characteristics	_
58-11	12700-12701	,	_
58-12	12702-12710	followed	_
58-13	12711-12714	the	_
58-14	12715-12729	reconstruction	_
58-15	12730-12740	procedures	_
58-16	12741-12742	(	_
58-17	12743-12747	http	_
58-18	12748-12749	:	_
58-19	12750-12811	//surfer.nmr.mgh.harvard.edu/fswiki/RecommendedReconstruction	_
58-20	12812-12813	)	_
58-21	12814-12816	to	_
58-22	12817-12825	identify	_
58-23	12826-12829	and	_
58-24	12830-12837	correct	_
58-25	12838-12841	any	_
58-26	12842-12848	errors	_
58-27	12849-12853	made	_
58-28	12854-12860	during	_
58-29	12861-12864	the	_
58-30	12865-12873	cortical	_
58-31	12874-12888	reconstruction	_
58-32	12889-12890	.	_

Text=Following inspection, an automated parcellation procedure divided each hemisphere into 32 independent cortical regions based on gyral and sulcal features.
59-1	12891-12900	Following	_
59-2	12901-12911	inspection	_
59-3	12912-12913	,	_
59-4	12914-12916	an	_
59-5	12917-12926	automated	_
59-6	12927-12939	parcellation	_
59-7	12940-12949	procedure	_
59-8	12950-12957	divided	_
59-9	12958-12962	each	_
59-10	12963-12973	hemisphere	_
59-11	12974-12978	into	_
59-12	12979-12981	32	_
59-13	12982-12993	independent	_
59-14	12994-13002	cortical	_
59-15	13003-13010	regions	_
59-16	13011-13016	based	_
59-17	13017-13019	on	_
59-18	13020-13025	gyral	_
59-19	13026-13029	and	_
59-20	13030-13036	sulcal	_
59-21	13037-13045	features	_
59-22	13046-13047	.	_

Text=See Table 2 for list of parcellated brain regions.
60-1	13048-13051	See	_
60-2	13052-13057	Table	_
60-3	13058-13059	2	_
60-4	13060-13063	for	_
60-5	13064-13068	list	_
60-6	13069-13071	of	_
60-7	13072-13083	parcellated	_
60-8	13084-13089	brain	_
60-9	13090-13097	regions	_
60-10	13098-13099	.	_

Text=Cortical thickness estimates of each region were extracted for subsequent statistical analyses.
61-1	13100-13108	Cortical	_
61-2	13109-13118	thickness	_
61-3	13119-13128	estimates	_
61-4	13129-13131	of	_
61-5	13132-13136	each	_
61-6	13137-13143	region	_
61-7	13144-13148	were	_
61-8	13149-13158	extracted	_
61-9	13159-13162	for	_
61-10	13163-13173	subsequent	_
61-11	13174-13185	statistical	_
61-12	13186-13194	analyses	_
61-13	13195-13196	.	_

Text=Functional image processing Analysis of Functional NeuroImages (AFNI; was used to process functional images.
62-1	13197-13207	Functional	_
62-2	13208-13213	image	_
62-3	13214-13224	processing	_
62-4	13225-13233	Analysis	_
62-5	13234-13236	of	_
62-6	13237-13247	Functional	_
62-7	13248-13259	NeuroImages	_
62-8	13260-13261	(	_
62-9	13262-13266	AFNI	_
62-10	13267-13268	;	_
62-11	13269-13272	was	_
62-12	13273-13277	used	_
62-13	13278-13280	to	_
62-14	13281-13288	process	_
62-15	13289-13299	functional	_
62-16	13300-13306	images	_
62-17	13307-13308	.	_

Text=Artifact and aberrant signal levels were examined in each repetition of each slice using an automated program developed by the UCSD Laboratory of Cognitive Neuroimaging.
63-1	13309-13317	Artifact	_
63-2	13318-13321	and	_
63-3	13322-13330	aberrant	_
63-4	13331-13337	signal	_
63-5	13338-13344	levels	_
63-6	13345-13349	were	_
63-7	13350-13358	examined	_
63-8	13359-13361	in	_
63-9	13362-13366	each	_
63-10	13367-13377	repetition	_
63-11	13378-13380	of	_
63-12	13381-13385	each	_
63-13	13386-13391	slice	_
63-14	13392-13397	using	_
63-15	13398-13400	an	_
63-16	13401-13410	automated	_
63-17	13411-13418	program	_
63-18	13419-13428	developed	_
63-19	13429-13431	by	_
63-20	13432-13435	the	_
63-21	13436-13440	UCSD	_
63-22	13441-13451	Laboratory	_
63-23	13452-13454	of	_
63-24	13455-13464	Cognitive	_
63-25	13465-13477	Neuroimaging	_
63-26	13478-13479	.	_

Text=Motion in time series data were corrected by registering each acquisition to the maximally stable base volume with an iterated least squares algorithm to estimate three rotational and three displacement parameters for each participant.
64-1	13480-13486	Motion	_
64-2	13487-13489	in	_
64-3	13490-13494	time	_
64-4	13495-13501	series	_
64-5	13502-13506	data	_
64-6	13507-13511	were	_
64-7	13512-13521	corrected	_
64-8	13522-13524	by	_
64-9	13525-13536	registering	_
64-10	13537-13541	each	_
64-11	13542-13553	acquisition	_
64-12	13554-13556	to	_
64-13	13557-13560	the	_
64-14	13561-13570	maximally	_
64-15	13571-13577	stable	_
64-16	13578-13582	base	_
64-17	13583-13589	volume	_
64-18	13590-13594	with	_
64-19	13595-13597	an	_
64-20	13598-13606	iterated	_
64-21	13607-13612	least	_
64-22	13613-13620	squares	_
64-23	13621-13630	algorithm	_
64-24	13631-13633	to	_
64-25	13634-13642	estimate	_
64-26	13643-13648	three	_
64-27	13649-13659	rotational	_
64-28	13660-13663	and	_
64-29	13664-13669	three	_
64-30	13670-13682	displacement	_
64-31	13683-13693	parameters	_
64-32	13694-13697	for	_
64-33	13698-13702	each	_
64-34	13703-13714	participant	_
64-35	13715-13716	.	_

Text=An output file specifying adjustments made controlled for spin history effects in analyses if no significant task-correlated motion was found.
65-1	13717-13719	An	_
65-2	13720-13726	output	_
65-3	13727-13731	file	_
65-4	13732-13742	specifying	_
65-5	13743-13754	adjustments	_
65-6	13755-13759	made	_
65-7	13760-13770	controlled	_
65-8	13771-13774	for	_
65-9	13775-13779	spin	_
65-10	13780-13787	history	_
65-11	13788-13795	effects	_
65-12	13796-13798	in	_
65-13	13799-13807	analyses	_
65-14	13808-13810	if	_
65-15	13811-13813	no	_
65-16	13814-13825	significant	_
65-17	13826-13841	task-correlated	_
65-18	13842-13848	motion	_
65-19	13849-13852	was	_
65-20	13853-13858	found	_
65-21	13859-13860	.	_

Text=To evaluate task-related motion, the reference vector was correlated with the six motion parameters for each dataset.
66-1	13861-13863	To	_
66-2	13864-13872	evaluate	_
66-3	13873-13885	task-related	_
66-4	13886-13892	motion	_
66-5	13893-13894	,	_
66-6	13895-13898	the	_
66-7	13899-13908	reference	_
66-8	13909-13915	vector	_
66-9	13916-13919	was	_
66-10	13920-13930	correlated	_
66-11	13931-13935	with	_
66-12	13936-13939	the	_
66-13	13940-13943	six	_
66-14	13944-13950	motion	_
66-15	13951-13961	parameters	_
66-16	13962-13965	for	_
66-17	13966-13970	each	_
66-18	13971-13978	dataset	_
66-19	13979-13980	.	_

Text=Datasets with significant task-correlated or bulk motion (> 2mm) were excluded from analyses.
67-1	13981-13989	Datasets	_
67-2	13990-13994	with	_
67-3	13995-14006	significant	_
67-4	14007-14022	task-correlated	_
67-5	14023-14025	or	_
67-6	14026-14030	bulk	_
67-7	14031-14037	motion	_
67-8	14038-14039	(	_
67-9	14040-14041	>	_
67-10	14042-14045	2mm	_
67-11	14046-14047	)	_
67-12	14048-14052	were	_
67-13	14053-14061	excluded	_
67-14	14062-14066	from	_
67-15	14067-14075	analyses	_
67-16	14076-14077	.	_

Text=Two trained raters then scanned the time series en cine to omit any remaining repetitions with visually discernible motion; if more than 15% of repetitions in a task were discarded, the run was not used (n=10, not described in this paper).
68-1	14078-14081	Two	_
68-2	14082-14089	trained	_
68-3	14090-14096	raters	_
68-4	14097-14101	then	_
68-5	14102-14109	scanned	_
68-6	14110-14113	the	_
68-7	14114-14118	time	_
68-8	14119-14125	series	_
68-9	14126-14128	en	_
68-10	14129-14133	cine	_
68-11	14134-14136	to	_
68-12	14137-14141	omit	_
68-13	14142-14145	any	_
68-14	14146-14155	remaining	_
68-15	14156-14167	repetitions	_
68-16	14168-14172	with	_
68-17	14173-14181	visually	_
68-18	14182-14193	discernible	_
68-19	14194-14200	motion	_
68-20	14201-14202	;	_
68-21	14203-14205	if	_
68-22	14206-14210	more	_
68-23	14211-14215	than	_
68-24	14216-14218	15	_
68-25	14219-14220	%	_
68-26	14221-14223	of	_
68-27	14224-14235	repetitions	_
68-28	14236-14238	in	_
68-29	14239-14240	a	_
68-30	14241-14245	task	_
68-31	14246-14250	were	_
68-32	14251-14260	discarded	_
68-33	14261-14262	,	_
68-34	14263-14266	the	_
68-35	14267-14270	run	_
68-36	14271-14274	was	_
68-37	14275-14278	not	_
68-38	14279-14283	used	_
68-39	14284-14285	(	_
68-40	14286-14290	n=10	_
68-41	14291-14292	,	_
68-42	14293-14296	not	_
68-43	14297-14306	described	_
68-44	14307-14309	in	_
68-45	14310-14314	this	_
68-46	14315-14320	paper	_
68-47	14321-14322	)	_
68-48	14323-14324	.	_

Text=Raw time series data were standardized to percent signal change from baseline, and deconvolution was conducted with a reference function that convolved the behavioral stimuli with a hemodynamic response model, while covarying for linear trends and motion correction, ignoring the first three repetitions.
69-1	14325-14328	Raw	_
69-2	14329-14333	time	_
69-3	14334-14340	series	_
69-4	14341-14345	data	_
69-5	14346-14350	were	_
69-6	14351-14363	standardized	_
69-7	14364-14366	to	_
69-8	14367-14374	percent	_
69-9	14375-14381	signal	_
69-10	14382-14388	change	_
69-11	14389-14393	from	_
69-12	14394-14402	baseline	_
69-13	14403-14404	,	_
69-14	14405-14408	and	_
69-15	14409-14422	deconvolution	_
69-16	14423-14426	was	_
69-17	14427-14436	conducted	_
69-18	14437-14441	with	_
69-19	14442-14443	a	_
69-20	14444-14453	reference	_
69-21	14454-14462	function	_
69-22	14463-14467	that	_
69-23	14468-14477	convolved	_
69-24	14478-14481	the	_
69-25	14482-14492	behavioral	_
69-26	14493-14500	stimuli	_
69-27	14501-14505	with	_
69-28	14506-14507	a	_
69-29	14508-14519	hemodynamic	_
69-30	14520-14528	response	_
69-31	14529-14534	model	_
69-32	14535-14536	,	_
69-33	14537-14542	while	_
69-34	14543-14552	covarying	_
69-35	14553-14556	for	_
69-36	14557-14563	linear	_
69-37	14564-14570	trends	_
69-38	14571-14574	and	_
69-39	14575-14581	motion	_
69-40	14582-14592	correction	_
69-41	14593-14594	,	_
69-42	14595-14603	ignoring	_
69-43	14604-14607	the	_
69-44	14608-14613	first	_
69-45	14614-14619	three	_
69-46	14620-14631	repetitions	_
69-47	14632-14633	.	_

Text=This resulted in a functional image in which every voxel contains a fit coefficient representing the change in signal across behavioral conditions, as well as percent signal change and threshold statistics.
70-1	14634-14638	This	_
70-2	14639-14647	resulted	_
70-3	14648-14650	in	_
70-4	14651-14652	a	_
70-5	14653-14663	functional	_
70-6	14664-14669	image	_
70-7	14670-14672	in	_
70-8	14673-14678	which	_
70-9	14679-14684	every	_
70-10	14685-14690	voxel	_
70-11	14691-14699	contains	_
70-12	14700-14701	a	_
70-13	14702-14705	fit	_
70-14	14706-14717	coefficient	_
70-15	14718-14730	representing	_
70-16	14731-14734	the	_
70-17	14735-14741	change	_
70-18	14742-14744	in	_
70-19	14745-14751	signal	_
70-20	14752-14758	across	_
70-21	14759-14769	behavioral	_
70-22	14770-14780	conditions	_
70-23	14781-14782	,	_
70-24	14783-14785	as	_
70-25	14786-14790	well	_
70-26	14791-14793	as	_
70-27	14794-14801	percent	_
70-28	14802-14808	signal	_
70-29	14809-14815	change	_
70-30	14816-14819	and	_
70-31	14820-14829	threshold	_
70-32	14830-14840	statistics	_
70-33	14841-14842	.	_

Text=Standardized Talairach transformations were made for each high-resolution anatomical image, and functional datasets were warped in accordance to manage individual anatomical variability.
71-1	14843-14855	Standardized	_
71-2	14856-14865	Talairach	_
71-3	14866-14881	transformations	_
71-4	14882-14886	were	_
71-5	14887-14891	made	_
71-6	14892-14895	for	_
71-7	14896-14900	each	_
71-8	14901-14916	high-resolution	_
71-9	14917-14927	anatomical	_
71-10	14928-14933	image	_
71-11	14934-14935	,	_
71-12	14936-14939	and	_
71-13	14940-14950	functional	_
71-14	14951-14959	datasets	_
71-15	14960-14964	were	_
71-16	14965-14971	warped	_
71-17	14972-14974	in	_
71-18	14975-14985	accordance	_
71-19	14986-14988	to	_
71-20	14989-14995	manage	_
71-21	14996-15006	individual	_
71-22	15007-15017	anatomical	_
71-23	15018-15029	variability	_
71-24	15030-15031	.	_

Text=Functional data were resampled into isotropic voxels (3 mm3), and a spatial smoothing Gaussian filter (full-width half maximum 5 mm) was applied to minimize the influence of individual anatomic variability.
72-1	15032-15042	Functional	_
72-2	15043-15047	data	_
72-3	15048-15052	were	_
72-4	15053-15062	resampled	_
72-5	15063-15067	into	_
72-6	15068-15077	isotropic	_
72-7	15078-15084	voxels	_
72-8	15085-15086	(	_
72-9	15087-15088	3	_
72-10	15089-15092	mm3	_
72-11	15093-15094	)	_
72-12	15095-15096	,	_
72-13	15097-15100	and	_
72-14	15101-15102	a	_
72-15	15103-15110	spatial	_
72-16	15111-15120	smoothing	_
72-17	15121-15129	Gaussian	_
72-18	15130-15136	filter	_
72-19	15137-15138	(	_
72-20	15139-15149	full-width	_
72-21	15150-15154	half	_
72-22	15155-15162	maximum	_
72-23	15163-15164	5	_
72-24	15165-15167	mm	_
72-25	15168-15169	)	_
72-26	15170-15173	was	_
72-27	15174-15181	applied	_
72-28	15182-15184	to	_
72-29	15185-15193	minimize	_
72-30	15194-15197	the	_
72-31	15198-15207	influence	_
72-32	15208-15210	of	_
72-33	15211-15221	individual	_
72-34	15222-15230	anatomic	_
72-35	15231-15242	variability	_
72-36	15243-15244	.	_

Text=Co-registration of structural images to functional images was performed with a mutual information registration program that robustly handles images with different signal characteristics and of different spatial resolutions.
73-1	15245-15260	Co-registration	_
73-2	15261-15263	of	_
73-3	15264-15274	structural	_
73-4	15275-15281	images	_
73-5	15282-15284	to	_
73-6	15285-15295	functional	_
73-7	15296-15302	images	_
73-8	15303-15306	was	_
73-9	15307-15316	performed	_
73-10	15317-15321	with	_
73-11	15322-15323	a	_
73-12	15324-15330	mutual	_
73-13	15331-15342	information	_
73-14	15343-15355	registration	_
73-15	15356-15363	program	_
73-16	15364-15368	that	_
73-17	15369-15377	robustly	_
73-18	15378-15385	handles	_
73-19	15386-15392	images	_
73-20	15393-15397	with	_
73-21	15398-15407	different	_
73-22	15408-15414	signal	_
73-23	15415-15430	characteristics	_
73-24	15431-15434	and	_
73-25	15435-15437	of	_
73-26	15438-15447	different	_
73-27	15448-15455	spatial	_
73-28	15456-15467	resolutions	_
73-29	15468-15469	.	_

Text=Volumetric and functional image alignment The AFNI SUrface MApper (SUMA; program was used to align segmented volumetric and functional datasets to the same template space.
74-1	15470-15480	Volumetric	_
74-2	15481-15484	and	_
74-3	15485-15495	functional	_
74-4	15496-15501	image	_
74-5	15502-15511	alignment	_
74-6	15512-15515	The	_
74-7	15516-15520	AFNI	_
74-8	15521-15528	SUrface	_
74-9	15529-15535	MApper	_
74-10	15536-15537	(	_
74-11	15538-15542	SUMA	_
74-12	15543-15544	;	_
74-13	15545-15552	program	_
74-14	15553-15556	was	_
74-15	15557-15561	used	_
74-16	15562-15564	to	_
74-17	15565-15570	align	_
74-18	15571-15580	segmented	_
74-19	15581-15591	volumetric	_
74-20	15592-15595	and	_
74-21	15596-15606	functional	_
74-22	15607-15615	datasets	_
74-23	15616-15618	to	_
74-24	15619-15622	the	_
74-25	15623-15627	same	_
74-26	15628-15636	template	_
74-27	15637-15642	space	_
74-28	15643-15644	.	_

Text=SUMA programs allow for fine control over the mapping between volume and surface domains produced by the FreeSurfer segmentation process while maintaining a direct link to volumetric data from which surface models and data originated.
75-1	15645-15649	SUMA	_
75-2	15650-15658	programs	_
75-3	15659-15664	allow	_
75-4	15665-15668	for	_
75-5	15669-15673	fine	_
75-6	15674-15681	control	_
75-7	15682-15686	over	_
75-8	15687-15690	the	_
75-9	15691-15698	mapping	_
75-10	15699-15706	between	_
75-11	15707-15713	volume	_
75-12	15714-15717	and	_
75-13	15718-15725	surface	_
75-14	15726-15733	domains	_
75-15	15734-15742	produced	_
75-16	15743-15745	by	_
75-17	15746-15749	the	_
75-18	15750-15760	FreeSurfer	_
75-19	15761-15773	segmentation	_
75-20	15774-15781	process	_
75-21	15782-15787	while	_
75-22	15788-15799	maintaining	_
75-23	15800-15801	a	_
75-24	15802-15808	direct	_
75-25	15809-15813	link	_
75-26	15814-15816	to	_
75-27	15817-15827	volumetric	_
75-28	15828-15832	data	_
75-29	15833-15837	from	_
75-30	15838-15843	which	_
75-31	15844-15851	surface	_
75-32	15852-15858	models	_
75-33	15859-15862	and	_
75-34	15863-15867	data	_
75-35	15868-15878	originated	_
75-36	15879-15880	.	_

Text=Combination of functional and structural neuroimaging data using SUMA is described in detail in Squeglia et al.
76-1	15881-15892	Combination	_
76-2	15893-15895	of	_
76-3	15896-15906	functional	_
76-4	15907-15910	and	_
76-5	15911-15921	structural	_
76-6	15922-15934	neuroimaging	_
76-7	15935-15939	data	_
76-8	15940-15945	using	_
76-9	15946-15950	SUMA	_
76-10	15951-15953	is	_
76-11	15954-15963	described	_
76-12	15964-15966	in	_
76-13	15967-15973	detail	_
76-14	15974-15976	in	_
76-15	15977-15985	Squeglia	_
76-16	15986-15988	et	_
76-17	15989-15991	al	_
76-18	15992-15993	.	_

Text=BOLD response values, averaged across the parcellation regions derived from FreeSurfer, were imported from AFNI to SPSS.
77-1	15994-15998	BOLD	_
77-2	15999-16007	response	_
77-3	16008-16014	values	_
77-4	16015-16016	,	_
77-5	16017-16025	averaged	_
77-6	16026-16032	across	_
77-7	16033-16036	the	_
77-8	16037-16049	parcellation	_
77-9	16050-16057	regions	_
77-10	16058-16065	derived	_
77-11	16066-16070	from	_
77-12	16071-16081	FreeSurfer	_
77-13	16082-16083	,	_
77-14	16084-16088	were	_
77-15	16089-16097	imported	_
77-16	16098-16102	from	_
77-17	16103-16107	AFNI	_
77-18	16108-16110	to	_
77-19	16111-16115	SPSS	_
77-20	16116-16117	.	_

Text=Statistical analysis Independent sample t-tests or Chi-square tests (for dichotomous variables) compared differences between groups (Table 1).
78-1	16118-16129	Statistical	_
78-2	16130-16138	analysis	_
78-3	16139-16150	Independent	_
78-4	16151-16157	sample	_
78-5	16158-16165	t-tests	_
78-6	16166-16168	or	_
78-7	16169-16179	Chi-square	_
78-8	16180-16185	tests	_
78-9	16186-16187	(	_
78-10	16188-16191	for	_
78-11	16192-16203	dichotomous	_
78-12	16204-16213	variables	_
78-13	16214-16215	)	_
78-14	16216-16224	compared	_
78-15	16225-16236	differences	_
78-16	16237-16244	between	_
78-17	16245-16251	groups	_
78-18	16252-16253	(	_
78-19	16254-16259	Table	_
78-20	16260-16261	1	_
78-21	16262-16263	)	_
78-22	16264-16265	.	_

Text=Random forests classification was implemented in R statistics (http: //cran.r-project.org; randomForest library) to predict alcohol initiator status, with missing data handled using the rfimpute function (see Table 1 for sample sizes per variable).
79-1	16266-16272	Random	_
79-2	16273-16280	forests	_
79-3	16281-16295	classification	_
79-4	16296-16299	was	_
79-5	16300-16311	implemented	_
79-6	16312-16314	in	_
79-7	16315-16316	R	_
79-8	16317-16327	statistics	_
79-9	16328-16329	(	_
79-10	16330-16334	http	_
79-11	16335-16336	:	_
79-12	16337-16357	//cran.r-project.org	_
79-13	16358-16359	;	_
79-14	16360-16372	randomForest	_
79-15	16373-16380	library	_
79-16	16381-16382	)	_
79-17	16383-16385	to	_
79-18	16386-16393	predict	_
79-19	16394-16401	alcohol	_
79-20	16402-16411	initiator	_
79-21	16412-16418	status	_
79-22	16419-16420	,	_
79-23	16421-16425	with	_
79-24	16426-16433	missing	_
79-25	16434-16438	data	_
79-26	16439-16446	handled	_
79-27	16447-16452	using	_
79-28	16453-16456	the	_
79-29	16457-16465	rfimpute	_
79-30	16466-16474	function	_
79-31	16475-16476	(	_
79-32	16477-16480	see	_
79-33	16481-16486	Table	_
79-34	16487-16488	1	_
79-35	16489-16492	for	_
79-36	16493-16499	sample	_
79-37	16500-16505	sizes	_
79-38	16506-16509	per	_
79-39	16510-16518	variable	_
79-40	16519-16520	)	_
79-41	16521-16522	.	_

Text=Default parameters for the randomForest function were used, with the exception of expanding the number of trees to 2000.
80-1	16523-16530	Default	_
80-2	16531-16541	parameters	_
80-3	16542-16545	for	_
80-4	16546-16549	the	_
80-5	16550-16562	randomForest	_
80-6	16563-16571	function	_
80-7	16572-16576	were	_
80-8	16577-16581	used	_
80-9	16582-16583	,	_
80-10	16584-16588	with	_
80-11	16589-16592	the	_
80-12	16593-16602	exception	_
80-13	16603-16605	of	_
80-14	16606-16615	expanding	_
80-15	16616-16619	the	_
80-16	16620-16626	number	_
80-17	16627-16629	of	_
80-18	16630-16635	trees	_
80-19	16636-16638	to	_
80-20	16639-16643	2000	_
80-21	16644-16645	.	_

Text=Random forests classification has been described in detail elsewhere.
81-1	16646-16652	Random	_
81-2	16653-16660	forests	_
81-3	16661-16675	classification	_
81-4	16676-16679	has	_
81-5	16680-16684	been	_
81-6	16685-16694	described	_
81-7	16695-16697	in	_
81-8	16698-16704	detail	_
81-9	16705-16714	elsewhere	_
81-10	16715-16716	.	_

Text=Briefly, random forests classification has two primary parameters: the number of trees (2000 used in these analyses) and the number of variables tried at each node (as recommended, the square root of the total number of variables).
82-1	16717-16724	Briefly	_
82-2	16725-16726	,	_
82-3	16727-16733	random	_
82-4	16734-16741	forests	_
82-5	16742-16756	classification	_
82-6	16757-16760	has	_
82-7	16761-16764	two	_
82-8	16765-16772	primary	_
82-9	16773-16783	parameters	_
82-10	16784-16785	:	_
82-11	16786-16789	the	_
82-12	16790-16796	number	_
82-13	16797-16799	of	_
82-14	16800-16805	trees	_
82-15	16806-16807	(	_
82-16	16808-16812	2000	_
82-17	16813-16817	used	_
82-18	16818-16820	in	_
82-19	16821-16826	these	_
82-20	16827-16835	analyses	_
82-21	16836-16837	)	_
82-22	16838-16841	and	_
82-23	16842-16845	the	_
82-24	16846-16852	number	_
82-25	16853-16855	of	_
82-26	16856-16865	variables	_
82-27	16866-16871	tried	_
82-28	16872-16874	at	_
82-29	16875-16879	each	_
82-30	16880-16884	node	_
82-31	16885-16886	(	_
82-32	16887-16889	as	_
82-33	16890-16901	recommended	_
82-34	16902-16903	,	_
82-35	16904-16907	the	_
82-36	16908-16914	square	_
82-37	16915-16919	root	_
82-38	16920-16922	of	_
82-39	16923-16926	the	_
82-40	16927-16932	total	_
82-41	16933-16939	number	_
82-42	16940-16942	of	_
82-43	16943-16952	variables	_
82-44	16953-16954	)	_
82-45	16955-16956	.	_

Text=In addition, trees were grown to the maximum possible number of nodes such that all participants in the bootstrap training sample were accurately classified.
83-1	16957-16959	In	_
83-2	16960-16968	addition	_
83-3	16969-16970	,	_
83-4	16971-16976	trees	_
83-5	16977-16981	were	_
83-6	16982-16987	grown	_
83-7	16988-16990	to	_
83-8	16991-16994	the	_
83-9	16995-17002	maximum	_
83-10	17003-17011	possible	_
83-11	17012-17018	number	_
83-12	17019-17021	of	_
83-13	17022-17027	nodes	_
83-14	17028-17032	such	_
83-15	17033-17037	that	_
83-16	17038-17041	all	_
83-17	17042-17054	participants	_
83-18	17055-17057	in	_
83-19	17058-17061	the	_
83-20	17062-17071	bootstrap	_
83-21	17072-17080	training	_
83-22	17081-17087	sample	_
83-23	17088-17092	were	_
83-24	17093-17103	accurately	_
83-25	17104-17114	classified	_
83-26	17115-17116	.	_

Text=Variable selection was accomplished using permutation importance scores, defined as the mean decrease in model accuracy when a predictor variable ’ s values are randomly permuted.
84-1	17117-17125	Variable	_
84-2	17126-17135	selection	_
84-3	17136-17139	was	_
84-4	17140-17152	accomplished	_
84-5	17153-17158	using	_
84-6	17159-17170	permutation	_
84-7	17171-17181	importance	_
84-8	17182-17188	scores	_
84-9	17189-17190	,	_
84-10	17191-17198	defined	_
84-11	17199-17201	as	_
84-12	17202-17205	the	_
84-13	17206-17210	mean	_
84-14	17211-17219	decrease	_
84-15	17220-17222	in	_
84-16	17223-17228	model	_
84-17	17229-17237	accuracy	_
84-18	17238-17242	when	_
84-19	17243-17244	a	_
84-20	17245-17254	predictor	_
84-21	17255-17263	variable	_
84-22	17264-17265	’	_
84-23	17266-17267	s	_
84-24	17268-17274	values	_
84-25	17275-17278	are	_
84-26	17279-17287	randomly	_
84-27	17288-17296	permuted	_
84-28	17297-17298	.	_

Text=Specifically, the random forests algorithm was first run 500 times on the entire set of possible predictors, to generate stable importance scores for each predictor (based on the median score across the 500 repetitions).
85-1	17299-17311	Specifically	_
85-2	17312-17313	,	_
85-3	17314-17317	the	_
85-4	17318-17324	random	_
85-5	17325-17332	forests	_
85-6	17333-17342	algorithm	_
85-7	17343-17346	was	_
85-8	17347-17352	first	_
85-9	17353-17356	run	_
85-10	17357-17360	500	_
85-11	17361-17366	times	_
85-12	17367-17369	on	_
85-13	17370-17373	the	_
85-14	17374-17380	entire	_
85-15	17381-17384	set	_
85-16	17385-17387	of	_
85-17	17388-17396	possible	_
85-18	17397-17407	predictors	_
85-19	17408-17409	,	_
85-20	17410-17412	to	_
85-21	17413-17421	generate	_
85-22	17422-17428	stable	_
85-23	17429-17439	importance	_
85-24	17440-17446	scores	_
85-25	17447-17450	for	_
85-26	17451-17455	each	_
85-27	17456-17465	predictor	_
85-28	17466-17467	(	_
85-29	17468-17473	based	_
85-30	17474-17476	on	_
85-31	17477-17480	the	_
85-32	17481-17487	median	_
85-33	17488-17493	score	_
85-34	17494-17500	across	_
85-35	17501-17504	the	_
85-36	17505-17508	500	_
85-37	17509-17520	repetitions	_
85-38	17521-17522	)	_
85-39	17523-17524	.	_

Text=The removal of poor performing variables can increase overall accuracy by increasing the relevance of included data to outcome prediction.
86-1	17525-17528	The	_
86-2	17529-17536	removal	_
86-3	17537-17539	of	_
86-4	17540-17544	poor	_
86-5	17545-17555	performing	_
86-6	17556-17565	variables	_
86-7	17566-17569	can	_
86-8	17570-17578	increase	_
86-9	17579-17586	overall	_
86-10	17587-17595	accuracy	_
86-11	17596-17598	by	_
86-12	17599-17609	increasing	_
86-13	17610-17613	the	_
86-14	17614-17623	relevance	_
86-15	17624-17626	of	_
86-16	17627-17635	included	_
86-17	17636-17640	data	_
86-18	17641-17643	to	_
86-19	17644-17651	outcome	_
86-20	17652-17662	prediction	_
86-21	17663-17664	.	_

Text=Therefore, these importance scores were used to select which predictor variables would be included in a more parsimonious final model.
87-1	17665-17674	Therefore	_
87-2	17675-17676	,	_
87-3	17677-17682	these	_
87-4	17683-17693	importance	_
87-5	17694-17700	scores	_
87-6	17701-17705	were	_
87-7	17706-17710	used	_
87-8	17711-17713	to	_
87-9	17714-17720	select	_
87-10	17721-17726	which	_
87-11	17727-17736	predictor	_
87-12	17737-17746	variables	_
87-13	17747-17752	would	_
87-14	17753-17755	be	_
87-15	17756-17764	included	_
87-16	17765-17767	in	_
87-17	17768-17769	a	_
87-18	17770-17774	more	_
87-19	17775-17787	parsimonious	_
87-20	17788-17793	final	_
87-21	17794-17799	model	_
87-22	17800-17801	.	_

Text=Because negative permutation importance scores are due to random variation around zero of the poor predictor variables, only variables with an importance score greater than the magnitude of the most negative score were used in the final model.
88-1	17802-17809	Because	_
88-2	17810-17818	negative	_
88-3	17819-17830	permutation	_
88-4	17831-17841	importance	_
88-5	17842-17848	scores	_
88-6	17849-17852	are	_
88-7	17853-17856	due	_
88-8	17857-17859	to	_
88-9	17860-17866	random	_
88-10	17867-17876	variation	_
88-11	17877-17883	around	_
88-12	17884-17888	zero	_
88-13	17889-17891	of	_
88-14	17892-17895	the	_
88-15	17896-17900	poor	_
88-16	17901-17910	predictor	_
88-17	17911-17920	variables	_
88-18	17921-17922	,	_
88-19	17923-17927	only	_
88-20	17928-17937	variables	_
88-21	17938-17942	with	_
88-22	17943-17945	an	_
88-23	17946-17956	importance	_
88-24	17957-17962	score	_
88-25	17963-17970	greater	_
88-26	17971-17975	than	_
88-27	17976-17979	the	_
88-28	17980-17989	magnitude	_
88-29	17990-17992	of	_
88-30	17993-17996	the	_
88-31	17997-18001	most	_
88-32	18002-18010	negative	_
88-33	18011-18016	score	_
88-34	18017-18021	were	_
88-35	18022-18026	used	_
88-36	18027-18029	in	_
88-37	18030-18033	the	_
88-38	18034-18039	final	_
88-39	18040-18045	model	_
88-40	18046-18047	.	_

Text=Importantly, this technique utilizes bootstrapped cross-validation to reduce overfitting.
89-1	18048-18059	Importantly	_
89-2	18060-18061	,	_
89-3	18062-18066	this	_
89-4	18067-18076	technique	_
89-5	18077-18085	utilizes	_
89-6	18086-18098	bootstrapped	_
89-7	18099-18115	cross-validation	_
89-8	18116-18118	to	_
89-9	18119-18125	reduce	_
89-10	18126-18137	overfitting	_
89-11	18138-18139	.	_

Text=In addition, using variable importance in the initial models to select predictors, and reporting accuracy, sensitivity, and specificity only from the final model avoids the problem of “ double dipping ”, i.e.
90-1	18140-18142	In	_
90-2	18143-18151	addition	_
90-3	18152-18153	,	_
90-4	18154-18159	using	_
90-5	18160-18168	variable	_
90-6	18169-18179	importance	_
90-7	18180-18182	in	_
90-8	18183-18186	the	_
90-9	18187-18194	initial	_
90-10	18195-18201	models	_
90-11	18202-18204	to	_
90-12	18205-18211	select	_
90-13	18212-18222	predictors	_
90-14	18223-18224	,	_
90-15	18225-18228	and	_
90-16	18229-18238	reporting	_
90-17	18239-18247	accuracy	_
90-18	18248-18249	,	_
90-19	18250-18261	sensitivity	_
90-20	18262-18263	,	_
90-21	18264-18267	and	_
90-22	18268-18279	specificity	_
90-23	18280-18284	only	_
90-24	18285-18289	from	_
90-25	18290-18293	the	_
90-26	18294-18299	final	_
90-27	18300-18305	model	_
90-28	18306-18312	avoids	_
90-29	18313-18316	the	_
90-30	18317-18324	problem	_
90-31	18325-18327	of	_
90-32	18328-18329	“	_
90-33	18330-18336	double	_
90-34	18337-18344	dipping	_
90-35	18345-18346	”	_
90-36	18347-18348	,	_
90-37	18349-18352	i.e	_
90-38	18353-18354	.	_

Text=the repeated extraction of test statistics from the same sample.
91-1	18355-18358	the	_
91-2	18359-18367	repeated	_
91-3	18368-18378	extraction	_
91-4	18379-18381	of	_
91-5	18382-18386	test	_
91-6	18387-18397	statistics	_
91-7	18398-18402	from	_
91-8	18403-18406	the	_
91-9	18407-18411	same	_
91-10	18412-18418	sample	_
91-11	18419-18420	.	_

Text=This approach is consistent with Ball et al., 2014.
92-1	18421-18425	This	_
92-2	18426-18434	approach	_
92-3	18435-18437	is	_
92-4	18438-18448	consistent	_
92-5	18449-18453	with	_
92-6	18454-18458	Ball	_
92-7	18459-18461	et	_
92-8	18462-18465	al.	_
92-9	18466-18467	,	_
92-10	18468-18472	2014	_
92-11	18473-18474	.	_

Text=Three sequential models were built in order to compare the following sets of variables (see Table 2): 1) demographic/behavioral variables only, 2) demographic/behavioral and neuropsychological test variables, and 3) demographic/behavioral, neuropsychological, and neuroimaging variables.
93-1	18475-18480	Three	_
93-2	18481-18491	sequential	_
93-3	18492-18498	models	_
93-4	18499-18503	were	_
93-5	18504-18509	built	_
93-6	18510-18512	in	_
93-7	18513-18518	order	_
93-8	18519-18521	to	_
93-9	18522-18529	compare	_
93-10	18530-18533	the	_
93-11	18534-18543	following	_
93-12	18544-18548	sets	_
93-13	18549-18551	of	_
93-14	18552-18561	variables	_
93-15	18562-18563	(	_
93-16	18564-18567	see	_
93-17	18568-18573	Table	_
93-18	18574-18575	2	_
93-19	18576-18577	)	_
93-20	18578-18579	:	_
93-21	18580-18581	1	_
93-22	18582-18583	)	_
93-23	18584-18606	demographic/behavioral	_
93-24	18607-18616	variables	_
93-25	18617-18621	only	_
93-26	18622-18623	,	_
93-27	18624-18625	2	_
93-28	18626-18627	)	_
93-29	18628-18650	demographic/behavioral	_
93-30	18651-18654	and	_
93-31	18655-18673	neuropsychological	_
93-32	18674-18678	test	_
93-33	18679-18688	variables	_
93-34	18689-18690	,	_
93-35	18691-18694	and	_
93-36	18695-18696	3	_
93-37	18697-18698	)	_
93-38	18699-18721	demographic/behavioral	_
93-39	18722-18723	,	_
93-40	18724-18742	neuropsychological	_
93-41	18743-18744	,	_
93-42	18745-18748	and	_
93-43	18749-18761	neuroimaging	_
93-44	18762-18771	variables	_
93-45	18772-18773	.	_

Text=See Supplementary Materials for models were run on 26 neuropsychological and 136 neuroimaging variables separately.
94-1	18774-18777	See	_
94-2	18778-18791	Supplementary	_
94-3	18792-18801	Materials	_
94-4	18802-18805	for	_
94-5	18806-18812	models	_
94-6	18813-18817	were	_
94-7	18818-18821	run	_
94-8	18822-18824	on	_
94-9	18825-18827	26	_
94-10	18828-18846	neuropsychological	_
94-11	18847-18850	and	_
94-12	18851-18854	136	_
94-13	18855-18867	neuroimaging	_
94-14	18868-18877	variables	_
94-15	18878-18888	separately	_
94-16	18889-18890	.	_

Text=The relatively wide range in baseline age (12 to 14 years) could have biased findings since those enrolled at age 14 survived two more years without initiating alcohol use; this was accounted for by including baseline and follow-up age in the models.
95-1	18891-18894	The	_
95-2	18895-18905	relatively	_
95-3	18906-18910	wide	_
95-4	18911-18916	range	_
95-5	18917-18919	in	_
95-6	18920-18928	baseline	_
95-7	18929-18932	age	_
95-8	18933-18934	(	_
95-9	18935-18937	12	_
95-10	18938-18940	to	_
95-11	18941-18943	14	_
95-12	18944-18949	years	_
95-13	18950-18951	)	_
95-14	18952-18957	could	_
95-15	18958-18962	have	_
95-16	18963-18969	biased	_
95-17	18970-18978	findings	_
95-18	18979-18984	since	_
95-19	18985-18990	those	_
95-20	18991-18999	enrolled	_
95-21	19000-19002	at	_
95-22	19003-19006	age	_
95-23	19007-19009	14	_
95-24	19010-19018	survived	_
95-25	19019-19022	two	_
95-26	19023-19027	more	_
95-27	19028-19033	years	_
95-28	19034-19041	without	_
95-29	19042-19052	initiating	_
95-30	19053-19060	alcohol	_
95-31	19061-19064	use	_
95-32	19065-19066	;	_
95-33	19067-19071	this	_
95-34	19072-19075	was	_
95-35	19076-19085	accounted	_
95-36	19086-19089	for	_
95-37	19090-19092	by	_
95-38	19093-19102	including	_
95-39	19103-19111	baseline	_
95-40	19112-19115	and	_
95-41	19116-19125	follow-up	_
95-42	19126-19129	age	_
95-43	19130-19132	in	_
95-44	19133-19136	the	_
95-45	19137-19143	models	_
95-46	19144-19145	.	_

Text=McNemar ’ s Chi-squared test was used to compare the three models.
96-1	19146-19153	McNemar	_
96-2	19154-19155	’	_
96-3	19156-19157	s	_
96-4	19158-19169	Chi-squared	_
96-5	19170-19174	test	_
96-6	19175-19178	was	_
96-7	19179-19183	used	_
96-8	19184-19186	to	_
96-9	19187-19194	compare	_
96-10	19195-19198	the	_
96-11	19199-19204	three	_
96-12	19205-19211	models	_
96-13	19212-19213	.	_

Text=Fifty-one percent of participants (n=70) transitioned into moderate to heavy alcohol use (using Figure 1 classification) by age 18.
97-1	19214-19223	Fifty-one	_
97-2	19224-19231	percent	_
97-3	19232-19234	of	_
97-4	19235-19247	participants	_
97-5	19248-19249	(	_
97-6	19250-19254	n=70	_
97-7	19255-19256	)	_
97-8	19257-19269	transitioned	_
97-9	19270-19274	into	_
97-10	19275-19283	moderate	_
97-11	19284-19286	to	_
97-12	19287-19292	heavy	_
97-13	19293-19300	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseScale
97-14	19301-19304	use	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseScale
97-15	19305-19306	(	_
97-16	19307-19312	using	_
97-17	19313-19319	Figure	_
97-18	19320-19321	1	_
97-19	19322-19336	classification	_
97-20	19337-19338	)	_
97-21	19339-19341	by	_
97-22	19342-19345	age	_
97-23	19346-19348	18	_
97-24	19349-19350	.	_

Text=Therefore, model accuracy for each random forests model was also compared to the base response rate using McNemar ’ s Chi-squared test.
98-1	19351-19360	Therefore	_
98-2	19361-19362	,	_
98-3	19363-19368	model	_
98-4	19369-19377	accuracy	_
98-5	19378-19381	for	_
98-6	19382-19386	each	_
98-7	19387-19393	random	_
98-8	19394-19401	forests	_
98-9	19402-19407	model	_
98-10	19408-19411	was	_
98-11	19412-19416	also	_
98-12	19417-19425	compared	_
98-13	19426-19428	to	_
98-14	19429-19432	the	_
98-15	19433-19437	base	_
98-16	19438-19446	response	_
98-17	19447-19451	rate	_
98-18	19452-19457	using	_
98-19	19458-19465	McNemar	_
98-20	19466-19467	’	_
98-21	19468-19469	s	_
98-22	19470-19481	Chi-squared	_
98-23	19482-19486	test	_
98-24	19487-19488	.	_

